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Summary 
Aboriginal and Torres Strait Islander people have higher rates of cardiac conditions, and 
lower access to health services aimed at preventing and treating these conditions, than non-
Indigenous Australians. The Better Cardiac Care for Aboriginal and Torres Strait Islander 
People—a project supported by the Australian Health Ministers’ Advisory Council—aims to 
reduce mortality and morbidity from cardiac conditions by increasing access to services, 
better managing risk factors and treatment, and by improving the coordination of care. 
This is the first national report on the 21 Better Cardiac Care measures that were developed 
to monitor the success of the project. It includes information for 4 full measures and 8 part 
measures for which national data were available, and outlines the data development work 
that is required to report on all 21 measures. 
Key findings 
The indicators provide examples of higher rates of mortality and morbidity from cardiac 
conditions for Aboriginal and Torres Strait Islander people, and lower rates of in-hospital 
treatment services, than for other Australians.  
• The age-standardised mortality rate for cardiac conditions for Indigenous Australians in 
2008–2012 was 212 per 100,000 compared with 133 per 100,000 for non-Indigenous 
Australians. 
• The age-standardised proportion of people who presented to a hospital with a severe 
heart attack (that is, a STEMI), and had a procedure to open a blocked or narrowed 
artery (that is, a PCI) in 2010–13 was 46% for Indigenous Australians and 70% for non-
Indigenous Australians. 
Access to cardiac prevention and treatment services for Indigenous Australians varied by 
state and by region. 
• For example, the proportion of Indigenous people who presented to a hospital with a 
STEMI and had a PCI in 2010–13 ranged from 21% in the Northern Territory to 62% in 
Western Australia, and from 29% in Very remote areas to 64% in Major cities.  
Over time, mortality from cardiac conditions for Indigenous Australians decreased 
significantly and access to cardiac care improved.  
• The age-standardised mortality rate for cardiac conditions for Indigenous Australians 
decreased by 41% between 1998 and 2012, from 347 to 215 per 100,000. 
• The age-standardised proportion of Indigenous people who presented to a hospital with 
a STEMI and had a PCI increased from 25% in 2004–05 to 46% in 2012–13.  
There are 17 Better Cardiac Care measures that require further data development to enable 
full reporting. The required improvements include linkage between data sets for information 
on post-hospital care and mortality, more details on hospital treatment, better coverage of 
Rheumatic Heart Disease registers, and new data collections on services provided by general 
practitioners and cardiologists.
   ix 
Table S1: Summary of Better Cardiac Care results for Indigenous Australians 
   Age-standardised rate  Indigenous 
Measure 
Crude rate 
Indigenous Indigenous Non-Indigenous 
Change 
over time NSW Vic Qld WA SA Tas ACT NT 
1.1 Annual health assessments, 2013–14 (%) 26 27 4  24 16 30 27 21 10 16 30 
1.3  Primary care practitioner follow-up              
 (i) Blood pressure check, 2012–13 (%) 87 n.a. n.a. n.a. 87 84 87 84 89 83 84 91 
 (ii) Discussed quitting smoking, 2012–13 (%) 40 n.a. n.a. n.a. 48 42 38 37 44 40 40 28 
2.1 Cardiac-related diagnostic items, 2013–14 (%) 2 4 4  4(a) 3(a) 4 3 3 (a) (a) 3 
3.1 ST-elevation myocardial infarction patients treated with percutaneous coronary 
intervention, 2010–13 (%) 50 46 70  56(a) 62(a) 48 62 56 
(a) (a) 
21 
3.3 Acute coronary syndrome patients who received diagnostic angiography or 
definitive revascularisation, 2010–13 (%) 45 48 56  46(a) 44(a) 35 60 54 (a) (a) 46 
3.5 People admitted to hospital with acute myocardial infarction who died in 
hospital, 2008–13 (%) 5 4 4  n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
4.2 (i) People with cardiac disease with Team Care Arrangements, 2013–14 (%) 29 22 12  23(a) 16(a) 24 17 12 (a) (a) 29 
 (ii) People with cardiac disease with a GP Management Plan, 2013–14 (%) 33 26 14  26(a) 18(a) 27 24 18 (a) (a) 32 
 (iii) People with cardiac disease with Allied Health Services, 2013–14 (%) 24 19 17  24(a) 20(a) 21 8 16 (a) (a) 9 
5.1 New and recurrent cases of acute rheumatic fever, 2010–2013 (no. per 
100,000) 53 53 0.2 X n.a. n.a. 26 61 n.a. n.a. n.a. 119 
5.2 Recurrent acute rheumatic fever, 2010–2013 (%) n.a. n.a. n.a. ↔ n.a. n.a. n.a. n.a. n.a. n.a. n.a. 34 
5.3 Benzathine penicillin doses, 2013 (% receiving >80% of doses) n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 33 
6.1 Hospitalisations for cardiac conditions, 2010–13 (no. per 1,000) 13 24 13 ↔ 19(a) 15(a) 27 29 22 (a) (a) 32 
6.2 (i) Deaths from cardiac conditions, 2008–2012 (no. per 100,000)  81   212   133   68 n.a. 66 104 80 n.a. n.a. 132 
  (ii) In-hospital deaths for patients admitted with cardiac conditions, 2008–13 
(no. per 100,000)  29   70   38   n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 
(a) Data for New South Wales are combined with data for the Australian Capital Territory, and data for Victoria are combined with data for Tasmania. 
 = improved over time for Indigenous Australians;  X = worsened over time for Indigenous Australians;  ↔ = no change over time for Indigenous Australians. 
Notes 
1. Data by state and territory for measures 2.1, 4.2 and 6.1 are age standardised, whereas state and territory data for the remaining measures are crude rates. 
2. Data for the Indigenous/non-Indigenous comparison for measure 5.1 are not age standardised. 
3. Change over time is measured over the following years: 2004–05 to 2013–14 for measures 1.1 and 1.3; 2004–05 and 2012–13 for measures 3.1, 3.3 and 6.1; 2004–07 and 2010–13 for measure 3.5; 2005–06 and  
2013–14 for measure 4.2; 2010 and 2013 for measures 5.1 and 5.2; 1998 and 2012 for measure 6.2. 
Sources: ABS 2012–13 Aboriginal and Torres Strait Islander Health Survey; AIHW analysis of Medical Benefits Schedule data; AIHW analysis of NT Rheumatic Heart Disease Program data; AIHW National Hospital Morbidity 
Database; AIHW National Mortality Database. 

  Better Cardiac Care measures for Aboriginal and Torres Strait Islander people 2015 11 
1 Introduction  
Heart and circulatory conditions contribute most to the disease burden of Aboriginal and 
Torres Strait Islander people and are major contributors to the gap in life expectancy 
between Indigenous and other Australians (Vos et al. 2009). Research evidence shows that, as 
well as having higher rates of cardiac conditions, Aboriginal and Torres Strait Islander 
people have poorer access to health services aimed at preventing and treating cardiac 
conditions (Clark et al. 2012; Mathur et al. 2006; Walters et al. 2008). 
The Better Cardiac Care for Aboriginal and Torres Strait Islander People project was an 
initiative of the Australian Health Ministers’ Advisory Council (AHMAC). It aims to reduce 
mortality and morbidity from cardiac conditions among Aboriginal and Torres Strait 
Islander people by increasing access to services, better managing risk factors and treatment 
and by improving the coordination of care. 
A related project, the Essential Service Standards for Equitable National Cardiovascular Care 
for Aboriginal and Torres Strait Islander people (ESSENCE), has produced standards on the 
essential services and care for Aboriginal and Torres Strait Islander people with 
cardiovascular disease. These standards were developed by a national steering committee of 
experts in Aboriginal and Torres Strait Islander cardiovascular care. Measures for these 
standards (some of which overlap the Better Cardiac Care measures) are being developed by 
project staff at the Wardliparingga Unit at the South Australian Health and Medical Research 
Institute. The aim of the ESSENCE measures is to assess performance against the ESSENCE 
standards and associated improvements in cardiovascular health outcomes. It is expected 
that implementing these ESSENCE measures will drive change in practice across the 
continuum of care.  
Better Cardiac Care project 
The Better Cardiac Care for Aboriginal and Torres Strait Islander People Forum, a joint 
initiative of Australian, state and territory governments, was held in March 2014 and 
involved representatives from both the Department of Health and state and territory health 
departments. The forum’s role was to identify national priorities for action and high-impact 
initiatives for implementation to improve cardiac outcomes for Aboriginal and Torres Strait 
Islander people.  
The post-forum report identified five priority areas for intervention and associated actions 
that health services should undertake to improve cardiac care for Aboriginal and Torres 
Strait Islander people (Better Cardiac Care Forum 2014). These five priority areas and actions 
recommended by the forum are outlined in Table 1.1. 
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Table 1.1: Priority areas and actions recommended by the Better Cardiac Care Forum(a) 
Priority area and action Responsibility 
Priority area 1: Primary preventive care─Early cardiovascular risk assessment and management 
1.1 Provide regular risk assessment and management of all identified risk factors Australian government 
1.2 Implement electronic quality improvement systems, along with quality assurance 
processes, in all primary health services 
All governments 
1.3 Support strategies to reduce smoking rates in Aboriginal and Torres Strait Islander 
people 
All governments 
Priority area 2: Clinical suspicion of disease─Timely diagnosis of heart disease and heart failure 
2.1 Develop or enhance regional cardiac service delivery plans, to improve the coordination 
of access to specialist physicians, and integrate the delivery of cardiac diagnostic services 
for Aboriginal and Torres Strait Islander people  
All governments 
 
Priority area 3: Acute episode─Guideline-based therapy for acute coronary syndrome 
3.1 Promote education in relation to the warning signs of heart disease and acute coronary 
syndrome for Aboriginal and Torres Strait Islander people 
State/territory governments 
3.2 Establish coordinated regional systems of care from point of first clinical contact to 
definitive care for patients presenting with acute coronary syndrome  
State/territory governments 
3.3 Implement nationally consistent systems to monitor timing and rates of reperfusion and 
revascularisation in Aboriginal and Torres Strait Islander people with acute coronary 
syndrome 
State/territory governments 
3.4 Develop a standard national clinical audit tool for acute coronary syndrome, which 
includes evaluation of pre, in- and post-hospital care 
State/territory governments 
Priority area 4: Ongoing care─Optimisation of health status and ongoing preventive care 
4.1 Ensure all patients admitted with cardiac conditions receive culturally appropriate cardiac 
education and commence cardiac rehabilitation while in hospital 
State/territory governments 
4.2 Ensure all patients admitted with cardiac conditions are automatically referred to the 
most appropriate primary health-care service able to provide or coordinate multidisciplinary 
secondary prevention services 
State/territory governments 
4.3 Deliver ongoing community-based, multidisciplinary chronic disease follow-up and 
specialist physician review as required for all Aboriginal and Torres Strait Islander people 
with cardiac disease 
All governments 
4.4 Expand the delivery of innovative cardiac rehabilitation and secondary prevention 
services that are appropriate for Aboriginal and Torres Strait Islander people 
All governments 
Priority area 5: Rheumatic heart disease─Strengthen the diagnosis, notification and follow-up of rheumatic heart 
disease 
5.1 Make rheumatic heart disease and acute rheumatic fever notifiable conditions in all 
jurisdictions 
All governments 
5.2 Consider the creation of a single national rheumatic heart disease/acute rheumatic fever 
register 
All governments 
5.2 Explore options to link data from the rheumatic heart disease registry to the Patient 
Controlled Electronic Health Record or equivalent 
All governments 
5.4 Increase clinicians’ awareness and capacity to diagnose and manage acute rheumatic 
fever and rheumatic heart disease, in line with the current Australian guidelines for the 
prevention, diagnosis and management of acute rheumatic fever and rheumatic heart 
disease, particularly in high-risk or endemic communities 
All governments 
5.5 Establish dedicated centres for Aboriginal and Torres Strait Islander heart surgery and 
rheumatic heart surgery where appropriate, to enable centralisation of expertise and the 
development of culturally appropriate specialist support services 
All governments 
(a) The AHMAC agreed to these priority areas and actions in June 2014. 
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The forum also developed a set of 21 Better Cardiac Care measures that were designed to 
ensure implementation and ongoing monitoring of these actions (Table 1.2). The Australian 
Institute of Health and Welfare (AIHW) was funded to prepare this first report on these 
21 measures. 
Reporting on the Better Cardiac Care measures  
The report includes data for 4 full measures and 8 part measures for which national data are 
currently available. Measures were reported in full where data were available, or partially 
where there were data available that closely approximated the original agreed measure. The 
report also outlines the data development work that is likely to be required to fully report on 
all 21 measures. The measures, their reporting status, main data sources and estimated data 
development time frames are summarised in Table 1.2. 
Table 1.2: Summary of Better Cardiac Care measures: reporting status, data sources and data 
development time frame  
Measure Data source Time frame  
Priority area 1: Early cardiovascular risk assessment and management 
1.1 Number/proportion of people who received an MBS Health Assessment within the previous 
12 months* MBS  
1.2 Number/per 1,000 people ≥20 years of age without cardiac disease with cardiovascular risk 
assessment and stratification in the last 2 years   Short term 
1.3 Proportion of people with risk factors for cardiac disease with evidence of primary care 
practitioner follow-up AATSIHS Long term 
Priority area 2: Timely diagnosis of heart disease and heart failure 
2.1 Number/proportion of clients with Medicare-listed diagnostic items claimed in the previous 
12 months* MBS  
2.2 Number/proportion of people who received diagnostic services within 30 days of referral   Long term 
2.3 Proportion of people with suspected/confirmed cardiac disease reviewed by a cardiologist 
within the previous 12 months  Long term 
Priority area 3: Guideline-based therapy for acute coronary syndrome 
3.1 Proportion of people with STEMI: (a) treated by primary PCI; (b) treated with fibrinolysis* NHMD Med term 
3.2 Proportion of people with STEMI who are not provided any reperfusion therapy NHMD Med term 
3.3 Proportion of people with ACS who received diagnostic angiography or definitive 
revascularisation procedure within the index admission/within 30 days* NHMD Med term 
3.4 Proportion of people diagnosed with ACS discharged from hospital on appropriate secondary 
prevention medicines   Med term 
3.5 In-hospital, 30-day and 12-month mortality rates for people admitted to hospital with a 
primary diagnosis of acute myocardial infarction* NHMD Short term 
Priority area 4: Optimisation of health status and provision of ongoing preventative care 
4.1 Number/proportion of patients reviewed by a primary health-care professional within 1 week 
of discharge from hospital  Short term 
4.2 Number/proportion of patients with cardiac disease who received follow-up Medicare items 
within 3 months of hospital discharge MBS Short term 
4.3 Number/proportion of patients with cardiac disease reviewed by a specialist physician within 
3/12 months of discharge   Short term 
4.4 Number/proportion of patients with coronary heart disease discharged on prevention 
medications and remaining on it at 3, 6 and 12 months   Med term 
(continued) 
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Table 1.2 (continued): Summary of Better Cardiac Care measures: reporting status, data sources and 
data development time frame 
Measure Data source Time frame  
Priority area 5: Strengthen the diagnosis, notification and follow-up of rheumatic heart disease 
5.1 Annual incidence of all acute rheumatic fever episodes 
RHDR Med term 
5.2 Proportion of all acute rheumatic fever episodes that are recurrent  RHDR Med term 
5.3 Median proportion of scheduled benzathine penicillin doses given to patients with 
confirmed acute rheumatic fever or rheumatic heart disease in the preceding 12 months RHDR Med term 
5.4 Proportion of people with moderate or severe rheumatic heart disease who received an 
echocardiogram in the previous 12 months  Long term 
Summary measures: Hospitalisation and mortality 
6.1 Age-standardised rates of hospitalisation for a cardiac condition  NHMD  
6.2 Age-standardised rates of cardiac mortality NMD  
 Green shading indicates 
national data are available to 
report on the full measure 
 Blue shading indicates that national 
data are available to report on part 
of the measures 
 Orange shading indicates that no data are 
available for national reporting 
* Indicates those measures for which AHMAC requested annual reporting (1.1, 2.1, 3.1, 3.3, and 3.5).  
AATSIHS = Aboriginal and Torres Strait Islander Health Survey; ACS = acute coronary syndrome; MBS = Medicare Benefit Schedule; NHMD = 
National Hospital Morbidity Database; NMD = National Mortality Database; PCI = percutaneous coronary intervention; RHDRs = Rheumatic Heart 
Disease registers; STEMI = ST-elevation myocardial infarction. 
Structure of this report 
Chapter 2 of this report includes the results for 12 measures for which national data were 
available, structured around the 5 priority areas. Each measure is reported on separately, 
including a description of the full measure and why it is important. Where available, the 
relevant data are presented at the national, state and regional levels; by age and sex; by 
Indigenous status; and by trends over time. Data presented at the national level for 
Indigenous Australians are crude rates, whereas data presented by Indigenous status are age 
standardised. A list of things to consider in interpreting the data for each measure is 
included to assist users understand any data issues and limitations.  
In some cases, the original indicators were modified to enable reporting. Appendix A 
outlines the original indicators and how these were modified. It also provides the technical 
specifications for all the measures reported. Information on the data sources used in this 
report is provided at Appendix B. Appendix C includes more information about the data 
issues and limitations listed under the ‘things to consider’ heading for each indicator. 
Chapter 3 of the report provides consolidated information on the data development work 
required to fully report on all 21 Better Cardiac Care measures. 
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2 Results 
Priority area 1: Early cardiovascular risk assessment 
and management 
The first priority area of the Better Cardiac Care project is early cardiovascular risk assessment 
and management. It is based on the premise that all Aboriginal and Torres Strait Islander 
people without known cardiac disease should receive a cardiovascular risk assessment each 
year, appropriate management and follow-up of identified risk factors, and lifestyle 
modification advice appropriate to their absolute cardiovascular risk level as per current 
guidelines (NACCHO/RACGP 2012). 
Primary prevention in the form of early and consistent risk factor identification and 
management will improve not only long-term outcomes for Aboriginal and Torres Strait 
Islander people (and reduce the population burden of chronic cardiac disease) but also the 
appropriate delivery of care by the health-care system. 
Three measures were agreed in this priority area: measure 1.1, on health assessments, is a 
national measure; measure 1.2, on cardiovascular disease risk assessment, and measure 1.3, 
on early management strategies, are service level measures. Data were available to fully 
report on measure 1.1 and to partly report on measure 1.3. 
Measure agreed at Better Cardiac Care Forum  Measure reported 
1.1 Number and proportion of regular Aboriginal and Torres 
Strait Islander clients of health services who received an MBS 
Health Assessment within the previous 12 months 
Data were reported for Aboriginal and Torres Strait Islanders 
aged 25 and over with an MBS Health Assessment. Persons 
aged under 25 were excluded due to the small numbers. 
1.3 Proportion of those Aboriginal and Torres Strait Islander 
people identified as having elevated risk of cardiac disease in 
the previous 2 years, with documented evidence of primary 
care practitioner follow-up, including the proportion 
commenced on anti-hypertensive and lipid-lowering therapy 
and proportion of smokers offered an evidence-based smoking 
cessation intervention 
No data on primary care practitioner follow-up were available 
so AATSIHS data were provided as a proxy. The measure 
reported was:  
(i) proportion of Indigenous people aged 18 and over living in 
non-remote areas without a current and long-term circulatory 
condition who were at high risk of cardiac disease who had 
their blood pressure checked in the last 2 years 
(ii) proportion of Indigenous people aged 18 and over without 
a current and long-term circulatory condition who were at 
high risk of cardiac disease and were current smokers who 
saw a doctor/health professional or specialist in the previous 
12 months and discussed quitting smoking. 
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Measure 1.1: Annual health assessments 
Proportion of people aged 25 and over who received a Medicare Benefits Schedule (MBS) 
Health Assessment within the previous 12 months. 
Why it is important 
Health assessments are intended to increase preventative health opportunities, detect 
chronic disease risk factors, better manage existing chronic disease and reduce inequities in 
access to primary care for Aboriginal and Torres Strait Islander people. Early detection and 
management of the risk factors for cardiac disease (smoking, physical inactivity, poor diet, 
high blood pressure) have the potential to reduce the incidence of cardiac disease and to 
lessen its severity. All Aboriginal and Torres Strait Islander people are eligible for an annual 
Indigenous-specific health assessment, listed as item 715 on the MBS. Both Indigenous and 
non-Indigenous people may also have a general MBS Health Assessment.  
Results 
Nationally: Just over one-quarter (26% or 81,086) of Indigenous people aged 25 and over had 
an MBS Health Assessment in 2013–14 (crude rate). 
Indigenous status: After adjusting for the age differences in the populations, Indigenous 
Australians aged 25 and over were 7 times as likely to have had an MBS Health Assessment 
as non-Indigenous Australians (27% compared with 4%) (Figure 1.1a). This higher figure 
reflects the creation of a specific MBS item for Indigenous people to address the health issue 
disadvantages they face. 
Time trend: In the 10 years from 2004–05 to 2013–14, the age-standardised proportion of 
Indigenous people aged 25 and over who had an MBS Health Assessment increased from 4% 
to 27% (Figure 1.1b). Over the same period, the proportion for non-Indigenous people 
increased from 2% to 4%. For Indigenous people, there was a particularly large increase from 
2008–09 (Figure 1.1b) which coincided with the introduction of the Australian Government’s 
Indigenous Chronic Disease Package.  
Age and sex 
• The proportion of Indigenous Australians who had an MBS Health Assessment 
increased with age, from 19% for those aged 25–34 to 37% for those aged 65 and over. 
• For each age group, Indigenous females were more likely than Indigenous males to have 
had an MBS Health Assessment (Figure 1.1c). 
• Rates were higher for Indigenous than for non-Indigenous males and females in all age 
groups. 
Jurisdiction: The proportion of Indigenous people aged 25 and over who had an MBS Health 
Assessment was highest in Queensland and the Northern Territory (both 30%), followed by 
Western Australia (27%). The proportion was lowest in Tasmania (10%) (Figure 1.1d). 
Region: Uptake of MBS Health Assessments was highest in Inner and outer regional areas 
(29%) and lowest in Major cities (19%) (Figure 1.1e). 
Things to consider 
• The MBS data reflect billing practices and not necessarily services provided.  
• The general health assessments data were adjusted for Indigenous under-identification. 
General health assessments for non-Indigenous Australians are not directly comparable 
with Indigenous-specific health assessments. 
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Source: AIHW analysis of MBS data. 
Figure 1.1a: Age-standardised proportion of 
people who had an MBS Health Assessment,  
by Indigenous status, 2013–14 
Source: AIHW analysis of MBS data. 
Figure 1.1b: Trends in age-standardised 
proportion of people who had an MBS  
Health Assessment, by Indigenous status 
 
Indigenous Non-Indigenous 
 
Source: AIHW analysis of MBS data. 
Figure 1.1c: Proportion of people who had an MBS Health Assessment, by Indigenous status, age 
and sex, 2013–14 
 
 
Source: AIHW analysis of MBS data. 
Figure 1.1d: Proportion of Indigenous people 
who had an MBS Health Assessment, by state 
and territory, 2013–14 
 
Source: AIHW analysis of MBS data. 
Figure 1.1e: Proportion of Indigenous people 
who had an MBS Health Assessment, by region, 
2013–14 
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Measure 1.3: Primary care practitioner follow-up 
(i) Proportion of Indigenous people aged 18 and over living in non-remote areas without a 
current and long-term circulatory condition who were at high risk of cardiac disease who 
had their blood pressure checked in the previous 2 years.  
(ii) Proportion of Indigenous people aged 18 and over without a current and long-term 
circulatory condition who were at high risk of cardiac disease and were current smokers who 
saw a doctor/health professional or specialist in the previous 12 months and discussed 
quitting smoking. 
Why it is important 
Active follow-up and management of risk factors for cardiac disease through regular 
monitoring, supporting smoking cessation and providing access to essential medicines are 
essential for maintaining health and reducing risk. 
Box 1: At high risk of cardiac disease 
Indigenous people were classified as being ‘at high risk of cardiac disease’ based on having 
one or more of the following: self-reported type 2 diabetes, self-reported hypertensive 
disease or measured high blood pressure (systolic or diastolic blood pressure  
>140/90 mmHg), self-reported high cholesterol, or current smoker (includes those who 
smoked daily, at least weekly, or less than weekly). 
Results 
1.3 (i) Blood pressure check 
Nationally: In 2012–13, in non-remote areas, 87% of Indigenous people without a circulatory 
condition who were at high risk of cardiac disease had their blood pressure checked in the 
last 2 years. 
Age and sex: The proportion of Indigenous Australians at high risk of cardiac disease who 
had their blood pressure checked in the last 2 years increased with age from 79% for those 
aged 18–24 to 98% for those aged 55 and over (Figure 1.3a). 
Jurisdiction: The proportion of Indigenous people at high risk of cardiac disease who had 
their blood pressure checked in the last 2 years was highest in the Northern Territory (91%), 
followed by South Australia (89%) (Figure 1.3b). 
Region: The proportion of Indigenous people at high risk of cardiac disease who had their 
blood pressure checked in the last 2 years was highest in Inner regional areas (90%) 
(Figure 1.3c). 
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Source: ABS 2012–13 AATSIHS. 
Figure 1.3a: Proportion of Indigenous people at 
high risk of cardiac disease who had their 
blood pressure checked in the last 2 years, by 
age and sex, 2012–13 
 
 
 
Source: ABS 2012–13 AATSIHS. 
Figure 1.3b: Proportion of Indigenous people at 
high risk of cardiac disease who had their blood 
pressure checked in the last 2 years, by state and 
territory, 2012–13 
 
Source: ABS 2012–13 AATSIHS. 
Figure 1.3c: Proportion of Indigenous people at 
high risk of cardiac disease who had their blood 
pressure checked in the last 2 years, by region, 
2012–13 
  
Male Female
           0
          20
          40
          60
          80
         100
18–24 25–34 35–44 45–54 55+
Per cent
Age group (years)
           0
          20
          40
          60
          80
         100
Jurisdiction
NSW Vic Qld WA SA Tas ACT NT
Per cent
           0
          20
          40
          60
          80
         100
Region
Major
cities
Inner
regional
Outer
regional
Per cent
 20 Better Cardiac Care measures for Aboriginal and Torres Strait Islander people 2015 
1.3 (ii) Discussed quitting smoking 
Nationally: In 2012–13, 40% of Indigenous people at high risk of cardiac disease who were 
current smokers and saw a doctor/health professional or specialist in the previous 12 
months and discussed quitting smoking. 
Age and sex: The proportion of Indigenous Australians at high risk of cardiac disease who 
discussed quitting smoking with their doctor/health professional or specialist in the 
previous 12 months increased with age from 33% for those aged 18–24 to 51% for those aged 
45–54 (Figure 1.3d). 
Jurisdiction: The Northern Territory had the lowest proportion of Indigenous people at high 
risk of cardiac disease who discussed quitting smoking with their doctor/health professional 
or specialist in the previous 12 months (28%) (Figure 1.3e). 
Region: The proportion of Indigenous people at high risk of cardiac disease who discussed 
quitting smoking with their doctor/health professional or specialist in the previous 12 
months decreased with remoteness, from 50% in Major cities to 27% in Very remote areas 
(Figure 1.3f). 
Things to consider 
• The data provided are proxy measures for primary care practitioner follow-up. 
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Source: ABS 2012–13 AATSIHS. 
Figure 1.3d: Proportion of Indigenous people  
at high risk of cardiac disease who discussed 
quitting smoking, by age and sex, 2012–13 
 
 
 
Source: ABS 2012–13 AATSIHS. 
Figure 1.3e: Proportion of Indigenous people at 
high risk of cardiac disease who discussed 
quitting smoking, by state and territory, 2012–13 
 
Source: ABS 2012–13 AATSIHS. 
Figure 1.3f: Proportion of Indigenous people at 
high risk of cardiac disease who discussed 
quitting smoking, by region, 2012–13 
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Priority area 2: Timely diagnosis of heart disease 
and heart failure 
The second priority area of the Better Cardiac Care project is timely diagnosis of heart disease 
and heart failure. It is based on the premise that all Aboriginal and Torres Strait Islander 
people suspected to have heart disease or heart failure should receive the appropriate initial 
diagnostic service (for example, stress testing or coronary angiography for ischaemic heart 
disease, echocardiography for heart failure and rheumatic heart disease, or other 
investigations as clinically indicated) as close to the patient’s home as possible, and within 
acceptable time frames according to the level of risk and the patient’s condition. 
Of the 3 measures recommended for this priority area, only measure 2.1 on Medicare-listed 
diagnostic items claimed in the previous 12 months is reported here. 
Measure agreed at Better Cardiac Care Forum  Measure reported 
2.1 Number and proportion of regular Aboriginal and Torres 
Strait Islander clients of health services who had relevant 
Medicare-listed diagnostic items claimed in the previous 
12 months, by region, compared with other Australians 
Same as agreed measure. 
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Measure 2.1: Cardiac-related diagnosis 
Number and proportion of Aboriginal and Torres Strait Islander people who had relevant 
Medicare diagnostic items claimed in the previous 12 months, in comparison with other 
Australians. 
Why it is important 
The level of access to diagnostic cardiac services in Australia varies considerably across 
regions and settings. This means that there is variation in the extent to which health-care 
professionals can provide appropriate treatment and follow-up. Data indicate that 
Aboriginal and Torres Strait Islander people have lower rates of angiography and other 
diagnostic services than other Australians, and that their access to these services is highly 
variable across Australia (AIHW 2013a). 
Results 
Nationally: In 2013–14, around 15,636 or 2% of Indigenous people had cardiac-related 
Medicare-listed diagnostic items claimed. There were 3 groups of these procedures: 6,255 or 
1% of Indigenous people had electrocardiogram (ECG) monitoring, 12,822 or 2% had 
echocardiography and 933 or 0.1% had cardiac catheterisation (with or without PCI). 
Indigenous status: The age-standardised proportions were slightly lower for Indigenous 
Australians than for non-Indigenous Australians, with a rate ratio of 0.9 for each of the 
3 procedure groups: ECG monitoring (1.5% compared with 1.7%, respectively), 
echocardiography (2.9% compared with 3.2%) and cardiac catheterisation (0.26% compared 
with 0.29%) (Figure 2.1a). 
Time trend: Between 2004–05 and 2013–14, the age-standardised proportion of Indigenous 
people who had Medicare-listed diagnostic items claimed increased from 1% to 4%. Over the 
same period, the proportion for non-Indigenous people remained fairly stable around 3–4% 
(Figure 2.1b). 
Age and sex: 
• The proportion of Indigenous Australians who had Medicare-listed cardiac-related 
diagnostic items claimed increased with age from 0.5% for those aged under 25 to 11% 
for those aged 65 and over (Figure 2.1c). 
• Proportions were similar for Indigenous males and females.  
Jurisdiction: The age-standardised proportion of Indigenous people who had 
Medicare-listed diagnostic items claimed was similar in all jurisdictions for both Indigenous 
and non-Indigenous Australians (Figure 2.1d). 
Region: For both Indigenous and non-Indigenous Australians, the age-standardised 
proportion who had claimed Medicare-listed diagnostic items was lower in Remote and very 
remote areas compared with other areas (Figure 2.1e). 
Things to consider 
• The MBS data reflect billing practices and not necessarily services provided. People may 
access these interventions (especially PCI) in public hospitals that are not captured in 
these data. 
• The MBS data were adjusted for Indigenous under-identification. 
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Source: AIHW analysis of MBS data. 
Figure 2.1a: Age-standardised proportion of 
people who had Medicare-listed diagnostic 
items claimed, by Indigenous status, 2012–14 
 
Source: AIHW analysis of MBS data. 
Figure 2.1b: Trends in age-standardised 
proportion of people who had Medicare-listed 
diagnostic items claimed, by Indigenous status 
 
Indigenous Non-Indigenous 
 
Source: AIHW analysis of MBS data. 
Figure 2.1c: Proportion of people who had Medicare-listed diagnostic items claimed, by  
Indigenous status, age and sex, 2013–14 
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Source: AIHW analysis of MBS data. 
Figure 2.1d: Age-standardised proportion of  
people who had Medicare-listed diagnostic 
items claimed, by Indigenous status, state and 
territory, 2013–14 
 
Source: AIHW analysis of MBS data. 
Figure 2.1e: Age-standardised proportion of 
people who had Medicare-listed diagnostic 
items claimed, by Indigenous status and region, 
2013–14 
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Priority area 3: Guideline-based therapy for acute 
coronary syndrome 
The third priority area of the Better Cardiac Care project is guideline-based therapy for acute 
coronary syndrome. It is based on the premise that all Aboriginal and Torres Strait Islander 
people with ACS, a broad spectrum of acute clinical presentations ranging from unstable 
angina to acute myocardial infarction, receive guideline-based therapy. 
Data for 3 of the 5 measures identified in this priority area are reported. 
Measure agreed at Better Cardiac Care Forum  Measure reported 
3.1 Proportion of people with STEMI who present within 12 
hours of symptom onset and are eligible to receive emergency 
reperfusion therapy who are (a) treated by primary PCI, (b) 
treated with fibrinolysis 
Data were not available to assess whether patients with a 
presented to emergency within 12 hours of symptom onset, 
nor on whether patients were eligible for reperfusion; hence, 
data on all people presenting with STEMI were reported. No 
data were available on whether patients were treated with 
fibrinolysis so this was not reported. People aged under 18 
were excluded due to the small numbers. 
3.3 Proportion of people with ACS who received diagnostic 
angiography or a definitive revascularisation procedure (PCI or 
coronary artery bypass graft) within the index admission and 
30 days of the index admission, by Aboriginal and Torres Strait 
Islander status 
Data were reported on estimates of people with ACS who 
received diagnostic angiography or a definitive 
revascularisation procedure within their period of care 
(contiguous episodes of care separated only by a transfer 
within or between hospitals). This was estimated by 
excluding hospitalisations ending in transfer to another acute 
hospital, so that only the ‘last’ hospitalisation was counted. 
Data were not available on whether these were received 
within 30 days of index admission. People aged under 18 
were excluded due to the small numbers. 
3.5 In-hospital, 30-day and 12-month mortality rates for people 
admitted to hospital with a primary diagnosis of acute 
myocardial infarction, by Aboriginal and Torres Strait Islander 
status 
Data were reported on in-hospital mortality for people aged 
35 and over who were admitted to hospital with a principal 
diagnosis of acute myocardial infarction. No national data 
were available on 30-day and 12-month mortality following 
hospitalisation. 
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Measure 3.1: STEMI patients treated by PCI 
Proportion of people aged 18 and over with a ST-elevation myocardial infarction (STEMI) 
who are treated by percutaneous coronary intervention (PCI) by Aboriginal and Torres Strait 
Islander status. 
Why it is important 
One of the most effective treatments for people presenting to hospitals with a STEMI (that is, 
a severe heart attack) is to unblock the affected artery by PCI (that is, a procedure such as 
stent that opens blocked or narrowed coronary arteries) (Pie’rard 2007). Across all states and 
territories, Aboriginal and Torres Strait Islander people have lower rates of access to 
reperfusion and revascularisation services, despite higher rates of hospitalisation and a 
higher proportion of Indigenous patients with ACS being ‘high-risk’ (Gausia et al. 2014).  
Results 
Nationally: Half (crude rate of 50%) of Indigenous people aged 18 and over with a STEMI 
were treated by PCI during the period 2010–13. 
Indigenous status: After adjusting for the age differences in the populations, 46% of 
Indigenous Australians with a STEMI were treated by PCI compared with 70% of 
non-Indigenous Australians (rate ratio of 0.7) (Figure 3.1a). 
Time trend: Between 2004–05 and 2012–13, the age-standardised proportion of Indigenous 
people with a STEMI who were treated by PCI almost doubled, from 25% to 46%. Over the 
same period, the equivalent proportion for non-Indigenous people increased from 52% to 
71% (Figure 3.1b). 
Age and sex: Indigenous males and females with a STEMI in all age groups were less likely 
than their non-Indigenous counterparts to be treated by PCI. For both Indigenous and 
non-Indigenous Australians, the proportion of people with a STEMI who were treated by 
PCI was lowest for those aged 65 and over (Figure 3.1c).  
Jurisdiction: The proportion of Indigenous people aged 18 and over with a STEMI who were 
treated by PCI was lowest in the Northern Territory (21%) and highest in Western Australia 
(62%) (Figure 3.1d).  
Region: The proportion of Indigenous people with a STEMI who were treated by PCI 
decreased with remoteness, from 64% in Major cities to 29% in Very remote areas (Figure 3.1e). 
Things to consider 
• The NHMD includes data on hospitalisations and not people, so the number of people is 
an estimate only. Hospitalisations ending in transfer to another acute hospital were 
excluded so that only the ‘last’ hospitalisation episode is counted. Analysis by NSW 
Health using linked hospital data showed that this method appears to overestimate the 
percentage of STEMI patients who receive PCI. 
• There is some under-identification of Indigenous people in the NHMD. 
• Eligibility for reperfusion therapy cannot be determined from the NHMD. 
• PCIs are also performed in a non-admitted patient setting but these are not captured in 
the NHMD.  
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Source: AIHW NHMD. 
Figure 3.1a: Age-standardised proportion of 
people with a STEMI treated by PCI, by 
Indigenous status, 2010–13 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 3.1b: Trends in age-standardised 
proportion of people with a STEMI treated by 
PCI, by Indigenous status 
 
Indigenous Non-Indigenous 
 
Source: AIHW NHMD. 
Figure 3.1c: Proportion of people with a STEMI treated by PCI, by Indigenous status, age and sex, 
2010–13 
 
 
Note: Data were reported by patient’s place of usual residence. 
Source: AIHW NHMD. 
Figure 3.1d: Proportion of Indigenous people 
with a STEMI treated by PCI, by state and 
territory, 2010–13 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 3.1e: Proportion of Indigenous people 
with a STEMI treated by PCI, by region,  
2009–12 
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Measure 3.3: Acute coronary syndrome patients who received 
diagnostic angiography or definitive revascularisation 
Proportion of people with an ACS who received one of the following within the period of 
care by Aboriginal and Torres Strait Islander status: 
• diagnostic angiography, or  
• a definitive revascularisation procedure, that is PCI or coronary artery bypass graft 
(open heart surgery with grafting of vessels). 
Why it is important 
Equitable access to acute cardiac care and adherence to cardiac care guidelines vary across 
hospitals, regions and for different patient groups (Gausia et al. 2014; Ong & Weeramanthri 
2000). Barriers to accessing timely ACS treatment can, in part, be explained by geographical 
disparity in services. Geographical mapping of cardiac services across Australia estimated 
that 60% of Aboriginal and Torres Strait Islander people cannot access a PCI-capable hospital 
within 1 hour of where they live (Clark et al. 2012). Other studies have indicated that the 
differences in procedures rates cannot be explained by place of residence alone, and rates of 
thrombolysis (an appropriate second-line alternative to PCI) and revascularisation 
procedures among Indigenous people are still lower in some settings than for other 
Australians living in the same area or accessing the same services (Cunningham 2002; Ong & 
Weeramanthri 2000; Prabhu et al. 2013; Randall et al. 2013).   
Results 
Nationally: In 2010–13, 45% of Indigenous people aged 18 and over with ACS received 
diagnostic angiography or a definitive revascularisation procedure (PCI or CABG) within the 
period of care. Of Indigenous people aged 18 and over with ACS, 44% received diagnostic 
angiography, 20% received PCI and 3% had a CABG within the period of care. 
Indigenous status 
• After adjusting for the age differences in the populations, 48% of Indigenous Australians 
with ACS received diagnostic angiography or definitive revascularisation compared 
with 56% of non-Indigenous Australians (rate ratio of 0.9) (Figure 3.3a). 
• Indigenous Australians with ACS were less likely to have received angiography than 
non-Indigenous Australians (47% compared with 54%, respectively, a rate ratio of 0.9) 
and were less likely to have received PCI (21% compared with 33%, a rate ratio of 0.7). 
• However, Indigenous Australians with ACS were more likely to have received CABG 
than non-Indigenous Australians (3.1% compared with 2.6%, respectively, a rate ratio of 
1.2). 
Time trend: Between 2004–05 and 2012–13, the age-standardised proportion of Indigenous 
people with ACS who received diagnostic angiography or a definitive revascularisation 
procedure increased from 29% to 51%. Over the same period, the proportion for 
non-Indigenous people increased from 48% to 57% (Figure 3.3b).  
Age and sex: The proportion of people with ACS who received diagnostic angiography or a 
definitive revascularisation procedure within the period of care was generally higher for 
non-Indigenous males and females than for Indigenous males and females (Figure 3.3c). 
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Source: AIHW NHMD. 
Figure 3.3a: Age-standardised proportion of 
people with ACS who received diagnostic 
angiography or a revascularisation procedure, 
by Indigenous status, 2010–13 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 3.3b: Trends in age-standardised 
proportion of people with ACS who received 
diagnostic angiography or a revascularisation 
procedure, by Indigenous status 
 
Indigenous Non-Indigenous 
 
Source: AIHW NHMD. 
Figure 3.3c: Proportion of people with ACS who received diagnostic angiography or a 
revascularisation procedure, by Indigenous status, age and sex, 2010–13 
 
 
Note: Data were reported by patient’s place of usual residence. 
Source: AIHW NHMD. 
Figure 3.3d: Proportion of Indigenous people 
with ACS who received diagnostic angiography 
or a revascularisation procedure, by state and 
territory, 2010–13 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 3.3e: Proportion of Indigenous people 
with ACS who received diagnostic angiography 
or a revascularisation procedure, by region, 
2009–12 
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Jurisdiction: The proportion of Indigenous people with ACS who received diagnostic 
angiography or a revascularisation procedure ranged from just over one-third (35%) in 
Queensland to 60% in Western Australia (Figure 3.3d). 
Region: The proportion of Indigenous people with ACS who received diagnostic 
angiography or a revascularisation procedure was lowest in Inner regional areas (34%) 
(Figure 3.3e). 
Things to consider 
• The NHMD includes data on hospitalisations, so the number of people is an estimate 
only. Hospitalisations ending in transfer to another acute hospital were excluded. The 
proportion of ACS patients who receive angiography or revascularisation may be 
underestimated. 
• There is some under-identification of Indigenous people in the NHMD.  
PCIs are also performed in a non-admitted patient setting but these are not captured in the 
NHMD.   
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Measure 3.5: Mortality rates for people admitted to hospital with 
acute myocardial infarction 
Proportion of people aged 35 and over, admitted to hospital with a principal diagnosis of 
acute myocardial infarction (AMI) who died in hospital, by Aboriginal and Torres Strait 
Islander status. 
Why it is important 
Improvements in treatment for people with AMI should result in decreases in the mortality 
rate over both the short and longer term (Ong & Weeramanthri 2000; Tideman et al. 2014). 
Results 
Nationally: In 2008–13, 5% of Indigenous people aged 35 and over who were admitted to 
hospital with AMI, died in hospital. 
Indigenous status: After adjusting for the age differences in the populations in 2008–13, 5% 
of Indigenous Australians with AMI died in hospital compared with 4% of non-Indigenous 
Australians (rate ratio of 1.1) (Figure 3.5a). 
Time trend: The proportion of Indigenous people with AMI who died in hospital decreased 
from 7% to 4% between 2004–07 and 2010–13. Over the same period, the rate for 
non-Indigenous people decreased from 6% to 4% (Figure 3.5b). 
Age and sex: In general, Indigenous males and females of all ages who were hospitalised 
with AMI were more likely than their non-Indigenous counterparts to die in hospital. The 
only exception to this was among the non-Indigenous females aged 65 and over (Figure 3.5c). 
The proportion of population surviving beyond age 65+ was highest for non-Indigenous 
females. 
Region: The proportion of Indigenous people with AMI who died in hospital was highest in 
Inner regional areas (7%) (Figure 3.5d). 
Things to consider 
• Data by jurisdiction could not be provided as they were not comparable due to different 
practices for recording deaths in the NHMD. Some jurisdictions recorded deaths in 
emergency departments as in-hospital deaths for admitted patients, while others did not. 
Inclusion of emergency department deaths would have resulted in an overestimate of 
the national rates presented in this report and would have potentially had an impact on 
the comparisons of Indigenous and non-Indigenous rates. 
• In-hospital mortality rates may also be affected by different approaches to pre- and 
post-hospital care, and should therefore be interpreted in the context of overall cardiac 
mortality. 
• While the indicator refers to proportions for people, the data presented for this indicator 
are based on proportions for hospitalisations. Hospitalisations ending in transfer to 
another acute hospital were excluded. Analysis by NSW Health using linked hospital 
data showed that this method appears to overestimate the in-hospital mortality rate. 
• There is some under-identification of Indigenous people in the NHMD. 
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Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 3.5a: Age-standardised proportion of 
people with AMI who died in hospital, by 
Indigenous status, 2008–13 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 3.5b: Trends in the age-standardised 
proportion of people with AMI who died in 
hospital, by Indigenous status 
 
Indigenous Non-Indigenous 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 3.5c: Proportion of people with AMI who died in hospital, by Indigenous status, age and 
sex, 2008–13 
 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 3.5d: Proportion of Indigenous people with  
AMI who died in hospital, by region, 2007–12 
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Priority area 4: Optimisation of health status and 
provision of ongoing preventive care 
The fourth priority area of the Better Cardiac Care project is optimisation of health status and 
provision of ongoing preventive care. It is based on the premise that all Aboriginal and Torres 
Strait Islander people with cardiac conditions should receive ongoing multidisciplinary 
primary health care and specialist physician follow-up as required, based on existing 
guidelines, to prevent further illness and to optimise health status, including active referral 
to allied and multidisciplinary health services for community-based cardiac rehabilitation 
services and ongoing risk factor management (National Heart Foundation of Australia 2010). 
Aboriginal and Torres Strait Islander people do not receive ongoing management of their 
cardiac or other chronic conditions after discharge from hospital at sufficient rates, despite 
bearing a considerably greater cardiovascular disease burden than non-Indigenous people.  
Of the 4 measures under this priority area, only part of measure 4.2 had data available for 
reporting. 
Measure agreed at Better Cardiac Care Forum  Measure reported 
4.2 Number and proportion of patients with documented 
evidence of receiving a Medicare Chronic Disease 
Management item (such as a Team Care Arrangement, 
General Practitioner Management Plan or Allied Health Service 
item) within 3 months of discharge from hospital, by Aboriginal 
and Torres Strait Islander status and region 
Data were reported on all people with cardiac disease 
receiving a Medicare Chronic Disease Management item of 
(a) Team Care Arrangement, (b) General Practitioner 
Management Plan (c) Allied Health Service. Data were not 
available specifically for patients discharged from hospital. 
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Measure 4.2: Medicare chronic disease management 
Number and proportion of patients with a cardiac condition (people who had one or more of 
the cardiac-related MBS items in Table A4) who received the following Medicare Chronic 
Disease management items by Aboriginal and Torres Strait Islander status and region: 
(i) Team Care Arrangement 
(ii) General Practitioner Management Plan (GPMP) 
(iii) Allied Health Service item(s). 
Why it is important 
Secondary prevention, which encompasses a broad range of multidisciplinary interventions 
and management (such as Team Care Arrangements and GPMPs) are important to reduce 
the recurrence of events or complications of disease in patients with an established diagnosis 
of cardiac disease. These interventions have been shown to reduce hospital readmission and 
mortality rates (National Heart Foundation of Australia 2006; WHO 1995). MBS data are the 
best source of data currently available to report on these areas.  
Results 
4.2 (i) Team Care Arrangements 
Nationally: In 2013–14, around 4,957 or 29% of Indigenous people with a cardiac condition 
also claimed a Medicare Team Care Arrangement item. 
Indigenous status: The age-standardised proportion was higher for Indigenous Australians 
(22%) than for non-Indigenous Australians (12%) (rate ratio 1.9) (Figure 4.2a). 
Time trend: Between 2005–06 and 2013–14, the age-standardised proportion of Indigenous 
people with a cardiac condition and a Team Care Arrangement increased from 5% to 22%. 
Over the same period, the proportion for non-Indigenous people increased from 3% to 12% 
(Figure 4.2b). 
Age and sex: 
• The proportions of Indigenous Australians with a cardiac condition and a Team Care 
Arrangement were higher than those for non-Indigenous Australians across all age 
groups, for both males and females. 
• The proportions for Indigenous Australians increased with age, rising from 9% for those 
aged under 25 to 38% for those aged 65 and over (Figure 4.2c).  
• The proportions for non-Indigenous Australians ranged from 5% for those aged under 
25 to 27% for those aged 65 and over. 
Jurisdiction: The age-standardised proportion of Indigenous people with a cardiac condition 
and a Team Care Arrangement was highest in the Northern Territory (29%) and lowest in 
South Australia (12%), while for non-Indigenous Australians it was highest in New South 
Wales/Australian Capital Territory (14%) and lowest in Western Australia (8%) 
(Figure 4.2d). 
Region: The age-standardised proportion of Indigenous Australians with a cardiac condition 
and a Team Care Arrangement was lowest in Major cities, while for non-Indigenous 
Australians it was lowest in Very remote areas (Figure 4.2e). 
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Source: AIHW analysis of MBS data. 
Figure 4.2a: Age-standardised proportion of 
people with a cardiac condition with a  
Team Care Arrangement, by Indigenous status, 
2013–14 
 
Source: AIHW analysis of MBS data. 
Figure 4.2b: Trends in age-standardised 
proportion of people with a cardiac condition 
with a Team Care Arrangement, by Indigenous 
status 
 
Indigenous Non-Indigenous 
 
Source: AIHW analysis of MBS data. 
Figure 4.2c: Proportion of people with a cardiac condition with a Team Care Arrangement, by 
Indigenous status, age and sex, 2013–14 
 
 
Source: AIHW analysis of MBS data. 
Figure 4.2d: Age-standardised proportion of 
people with a cardiac condition with a Team 
Care Arrangement, by Indigenous status, state 
and territory, 2013–14 
 
Source: AIHW analysis of MBS data. 
Figure 4.2e: Age-standardised proportion of 
people with a cardiac condition with a Team 
Care Arrangement, by Indigenous status and 
region, 2013–14 
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4.2 (ii) General Practitioner Management Plans 
Nationally: In 2013–14, around 5,647 or 33% of Indigenous people with a cardiac condition 
also had a GPMP. 
Indigenous status: The age-standardised proportion was higher for Indigenous Australians 
(26%) than for non-Indigenous Australians (14%) (rate ratio 1.8) (Figure 4.2f). 
Time trend: Between 2005–06 and 2013–14, the age-standardised proportion of Indigenous 
people with a cardiac condition who also had a GPMP increased from 10% to 26%. Over the 
same period, the corresponding proportion for non-Indigenous people increased from 6% to 
14% (Figure 4.2g). 
Age and sex: 
• The proportions of Indigenous Australians with a cardiac condition who also had a 
GPMP were higher than those for non-Indigenous Australians across all age groups, for 
both males and females. 
• The proportions for Indigenous Australians increased with age rising from 12% for those 
aged under 25 to 43% for those aged 65 and over (Figure 4.2h).  
• The proportions for non-Indigenous Australians ranged from 6% for those aged under 
25 to 32% for those aged 65 and over. 
Jurisdiction: The age-standardised proportion of Indigenous people with a cardiac condition 
who also had a GPMP was highest in the Northern Territory (32%) and lowest in 
Victoria/Tasmania (18%), while for non-Indigenous Australians it was highest in New South 
Wales/Australian Capital Territory (16%) and lowest in Western Australia (10%) 
(Figure 4.2i). 
Region: The age-standardised proportion of Indigenous Australians with a cardiac condition 
who also had a GPMP was lowest in Major cities, while for non-Indigenous Australians it 
was lowest in Very remote areas (Figure 4.2j). 
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Source: AIHW analysis of MBS data. 
Figure 4.2f: Age-standardised proportion of 
people with a cardiac condition with a GPMP, 
by Indigenous status, 2013–14 
 
Source: AIHW analysis of MBS data. 
Figure 4.2g: Trends in age-standardised 
proportion of people with a cardiac condition 
with a GPMP, by Indigenous status 
 
Indigenous Non-Indigenous 
 
Source: AIHW analysis of MBS data. 
Figure 4.2h: Proportion of people with a cardiac condition with a GPMP, by Indigenous status, age  
and sex, 2013–14 
 
 
Source: AIHW analysis of MBS data. 
Figure 4.2i: Age-standardised proportion of 
people with a cardiac condition with a GPMP,  
by Indigenous status, state and territory, 2013–14 
 
Source: AIHW analysis of MBS data. 
Figure 4.2j: Age-standardised proportion of 
people with a cardiac condition with a GPMP, 
by Indigenous status and region, 2013–14 
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4.2 (iii) Allied Health Service items 
Nationally: In 2013–14, around 4,187 or 24% of Indigenous people with a cardiac condition 
also claimed at least 1 Allied Health Service item. 
Indigenous status: The age-standardised proportion was similar for Indigenous Australians 
(19%) and non-Indigenous Australians (17%) (rate ratio 1.1) (Figure 4.2k). 
Time trend: Between 2005–06 and 2013–14, the age-standardised proportion of Indigenous 
people with a cardiac condition who also had an Allied Health Service increased from 2% to 
19%. Over the same period, the proportion for non-Indigenous people increased by a similar 
amount from 2% to 17% (Figure 4.2l). 
Age and sex: 
• The proportions of Indigenous Australians with a cardiac condition who also had an 
Allied Health Service were higher than those for non-Indigenous Australians in most age 
groups—for males aged from 25 and over and for females from 35 and over. 
• The proportions for Indigenous Australians increased with age, rising from 10% for 
those aged under 25 to 39% for those aged 65 and over (Figure 4.2m).  
• The proportions for non-Indigenous Australians ranged from 12% for those aged under 
25 to 32% for those aged 65 and over. 
Jurisdiction: The age-standardised proportion of Indigenous people with a cardiac condition 
who also had an Allied Health Service was highest in New South Wales/Australian Capital 
Territory (24%) and lowest in Western Australia (8%), while for non-Indigenous Australians 
it was highest in Victoria/Tasmania (18%) and lowest in the Northern Territory (8%) 
(Figure 4.2n). 
Region: The age-standardised proportion of those with a cardiac condition who also had an 
Allied Health Service was lowest in Remote and Very remote areas for both Indigenous and 
non-Indigenous Australians (Figure 4.2o). 
Things to consider 
• The MBS data reflect claiming practices and not necessarily services provided.  
•  The MBS data were adjusted for Indigenous under-identification. 
• As some of the MBS items used to identify people with a cardiac condition are 
diagnostic, not all people with these items would have cardiac conditions (as some of the 
tests would have been negative). 
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Source: AIHW analysis of MBS data. 
Figure 4.2k: Age-standardised proportion of 
people with a cardiac condition with an Allied 
Health Service item, by Indigenous status,  
2013–14 
 
Source: AIHW analysis of MBS data. 
Figure 4.2l: Trends in age-standardised 
proportion of people with a cardiac condition 
with an Allied Health Service item, by 
Indigenous status 
 
Indigenous Non-Indigenous 
 
Source: AIHW analysis of MBS data. 
Figure 4.2m: Proportion of people with a cardiac condition with an Allied Health Service item, by 
Indigenous status, age and sex, 2013–14 
 
 
Source: AIHW analysis of MBS data. 
Figure 4.2n: Age-standardised proportion of  
people with a cardiac condition with an Allied 
Health Service item, by Indigenous status, state 
and territory, 2013–14 
 
Source: AIHW analysis of MBS data. 
Figure 4.2o: Age-standardised proportion of 
people with a cardiac condition with an Allied 
Health Service item, by Indigenous status and 
region, 2013–14 
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Priority area 5: Strengthen the diagnosis, 
notification and follow-up of rheumatic heart disease 
The fifth priority area is strengthen the diagnosis, notification and follow-up of rheumatic heart 
disease. It is based on the premise that all Aboriginal and Torres Strait Islander people 
suspected to have ARF or RHD should receive an echocardiogram as early as possible. In 
addition, new cases should be automatically reported to a central register, to facilitate 
tracking of patients and ensure ongoing care (AIHW 2013c; National Heart Foundation of 
Australia 2006). 
There were 4 measures under this priority area, with data available to partly report on 3 of 
them. 
Measure agreed at Better Cardiac Care Forum  Measure reported 
5.1 Annual incidence of all ARF episodes, by Aboriginal 
and Torres Strait Islander status 
For some registers, data on new and recurrent cases could not be 
separated, so data were reported on both new and recurrent cases 
for NT, WA and Qld combined. Consistent national data were not 
available. 
5.2 Proportion of all ARF episodes that are recurrent, by 
Aboriginal and Torres Strait Islander status  
Same as agreed measure. But data were reported on recurrent 
episodes for NT only. Data were not available for other 
jurisdictions. 
5.3 Median proportion of scheduled benzathine penicillin 
doses given to patients with confirmed ARF or RHD in 
the preceding 12 months, by Aboriginal and Torres Strait 
Islander status 
Data were reported on the percentage of required doses of 
benzathine penicillin received in the previous 12 months for NT 
only. 
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Measure 5.1: Incidence of acute rheumatic fever 
Incidence (new and recurrent cases) of ARF, by Aboriginal and Torres Strait Islander status. 
Why it is important 
ARF can cause permanent damage to the heart; when this occurs, it is known as RHD. In 
Australia, ARF occurs among Aboriginal and Torres Strait Islander people but is seen very 
rarely in other populations. The clinical manifestation of ARF is non-specific and can be 
atypical in Indigenous people; therefore, many cases of ARF can go undetected in the acute 
stage, leading to ongoing complications and lifelong morbidity (RHD Australia 2012). 
Results 
Nationally: In the period 2010–2013, there were 743 new and recurrent cases of ARF in the 
Northern Territory, Western Australia and Queensland combined—a rate of 53 per 100,000. 
Indigenous status: In Queensland, Western Australia and the Northern Territory combined, 
the rate of new and recurrent cases of ARF was higher for Indigenous Australians than for 
other Australians (53 per 100,000 compared with 0.2 per 100,000) (Figure 5.1a). 
Time trend: The rate of new and recurrent cases of ARF increased from 37 to 73 per 100,000 
between 2010 and 2012, then decreased to 54 per 100,000 in 2013 (Figure 5.1b). 
Age and sex: 
• The rate of new and recurrent cases of ARF was highest for those aged 5–14, and then 
decreased with age (Figure 5.1c). 
• In each age group, except those aged 5–14, the rate of new and recurrent cases of ARF 
was higher for females than males. 
Jurisdiction: The Northern Territory had the highest rate of new and recurrent cases of ARF 
(119 per 100,000), followed by Western Australia (61 per 100,000) and Queensland (26 per 
100,000) (Figure 5.1d). 
Things to consider 
• Data on the incidence of ARF were available for the Northern Territory, Queensland and 
Western Australia only. 
• All rates are crude rates as data were not available for age standardisation. 
• There is no diagnostic laboratory test for ARF, so its diagnosis is based on a clinical 
decision. The clinical appearances of ARF are non-specific and can be atypical in 
Aboriginal and Torres Strait Islander people, so many cases can go undetected. 
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Note: Includes Qld, WA and NT combined. 
Source: AIHW 2015.  
Figure 5.1a: New and recurrent cases of ARF, by 
Indigenous status, 2010–2013 
 
Note: Includes Qld, WA and NT combined. 
Source: AIHW 2015. 
Figure 5.1b: Trends in new and recurrent cases 
of ARF among Indigenous Australians 
 
 
Note: Includes Qld, WA and NT combined. 
Source: AIHW 2015. 
Figure 5.1c: New and recurrent cases of ARF 
among Indigenous Australians, by age and sex, 
2010–2013 
 
Source: AIHW 2015. 
Figure 5.1d: New and recurrent cases of ARF 
among Indigenous Australians, by state and 
territory, 2010–2013 
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Measure 5.2: Recurrent acute rheumatic fever 
Proportion of all ARF episodes that are recurrent, by Aboriginal and Torres Strait Islander 
status. 
Why it is important 
Treatment of ARF is aimed at preventing disease recurrence and the development of RHD, 
and involves prolonged use of antibiotics. Rates of recurrent ARF are an indicator of the 
success of this secondary prevention treatment (National Heart Foundation of Australia 
2006). 
Results 
Nationally: In the period 2010–2013, 34% of ARF episodes for Indigenous people in the 
Northern Territory were recurrent. 
Indigenous status: Just over one-third (34%) of episodes of ARF for Indigenous people were 
recurrent compared with 11% of episodes for other Australians (Figure 5.2a). 
Time trend: The proportion of ARF episodes for Indigenous people that were recurrent 
ranged from 31% in 2012 to 41% in 2011 (Figure 5.2b). 
Age: The proportion of ARF episodes for Indigenous people that were recurrent increased 
with age, from 18% for those aged under 15 to 55%–57% for those aged 25 and over 
(Figure 5.2c). 
Things to consider 
• Data on recurrent cases were provided for the Northern Territory only. 
• All rates are crude rates as data were not available for age standardisation. 
• There is no diagnostic laboratory test for ARF, so its diagnosis is based on a clinical 
decision. The clinical appearances of ARF are non-specific and can be atypical in 
Aboriginal and Torres Strait Islander people, so many cases of ARF can go undetected. 
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Source: AIHW analysis of Northern Territory Rheumatic Heart Disease 
Program data. 
Figure 5.2a: Proportion of ARF episodes that are 
recurrent, by Indigenous status, 2010–2013 
 
Source: AIHW analysis of Northern Territory Rheumatic Heart Disease 
Program data. 
Figure 5.2b: Trends in proportion of ARF 
episodes that are recurrent among Indigenous 
Australians 
 
 
 
Source: AIHW analysis of Northern Territory Rheumatic Heart Disease 
Program data. 
Figure 5.2c: Proportion of Indigenous ARF 
episodes that are recurrent, by age, 2010–2013 
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Measure 5.3: Benzathine penicillin doses 
Percentage of required doses received in the previous 12 months for Indigenous persons on 
the ARF/RHD program. 
Why it is important 
Treatment of ARF and RHD involves use of benzathine penicillin over a prolonged period of 
time. This measure assesses what proportion of Indigenous patients receive the number of 
doses of penicillin required. Failure of treatment may lead to recurrence of ARF and 
development of RHD (National Heart Foundation of Australia 2006).  
Results 
Almost one-quarter (24%) of Indigenous people on the ARF/RHD program in the Northern 
Territory received less than 50% of required doses in the previous 12 months, 42% received 
50% to 80% and 33% received greater than 80% (Figure 5.3). 
Things to consider 
• Data on prophylaxis were provided for the Northern Territory only. 
 
 
Source: AIHW 2015. 
Figure 5.3: Adherence to secondary prophylaxis 
in the previous 12 months for Indigenous 
people on the ARF/RHD program, Northern 
Territory, 2013 
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Summary measures: hospitalisation and mortality 
Overview  
As well as the measures relating to the priority action areas, there are 2 summary measures 
designed to monitor hospitalisations and mortality from cardiac conditions. These measures 
provide a population-wide perspective on the impact of cardiac conditions over time, and 
can be reported using existing data collections. 
Measure agreed at Better Cardiac Care Forum  Measure reported 
6.1 Age-standardised rates of hospitalisation for a cardiac 
condition, by Aboriginal and Torres Strait Islander status 
Same as agreed measure. 
6.2 Age-standardised rates of cardiac mortality, by Aboriginal and 
Torres Strait Islander status 
Same as agreed measure. As well, an indicator of 
in-hospital mortality for patients admitted with cardiac 
conditions was also reported. 
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Measure 6.1: Hospitalisations for cardiac conditions 
Cardiac morbidity—age-standardised rates of hospitalisation for a cardiac condition, by 
Aboriginal and Torres Strait Islander status. 
Why it is important 
The hospitalisation rate for cardiac conditions provides a measure of the extent of serious 
cardiac conditions requiring hospitalisation and is a broad indicator of the effectiveness of 
early risk assessment and preventative care. 
Results 
Nationally: In 2010–13, there were around 25,500 Indigenous hospitalisations for cardiac 
conditions (a rate of 13 per 1,000 population). 
Indigenous status: The age-standardised hospitalisation rate due to cardiac conditions for 
Indigenous people was 1.8 times that of non-Indigenous people (24 and 13 per 1,000, 
respectively) (Figure 6.1a). 
Time trend: Between 2004–05 and 2012–13, age-standardised hospitalisation rates for cardiac 
conditions remained unchanged for both Indigenous and non-Indigenous Australians 
(Figure 6.1b). 
Age and sex: 
• In all age groups, Indigenous males and females were hospitalised for cardiac conditions 
at a higher rate than non-Indigenous males and females (Figure 6.1c). 
• Hospitalisation rates for cardiac conditions increased with age for both Indigenous and 
non-Indigenous Australians; however, Indigenous Australians experienced higher rates 
of hospitalisation than non-Indigenous Australians at younger ages. 
Jurisdiction: Age-standardised hospitalisation rates for cardiac conditions were highest for 
Indigenous people in the Northern Territory (32 per 1,000) and Western Australia (29 per 
1,000). In both these jurisdictions, Indigenous Australians were hospitalised for a cardiac 
condition at more than twice the rate of non-Indigenous Australians (Figure 6.1d). 
Region: Age-standardised hospitalisation rates for cardiac conditions were highest for 
Indigenous people in Outer regional and remote areas combined. In this area, Indigenous 
Australians were hospitalised for cardiac conditions at 2.5 times the rate of non-Indigenous 
Australians (Figure 6.1e). Note that population data are combined for Outer regional and 
Remote areas of Victoria and therefore rates based on population data cannot be presented 
separately for these regions. 
Things to consider 
• There is some under-identification of Indigenous people in the NHMD. 
• This is a count of hospitalisations, not of people hospitalised with cardiac conditions, nor 
of hospitalised cardiac events. Some hospitalisations would not have been associated 
with diagnoses that represent ‘coronary events’, and/or they would represent transfers 
for ongoing care. This should be interpreted in the context of pre- and post-hospital care 
arrangements. 
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Source: AIHW NHMD. 
 
Figure 6.1a: Age-standardised hospitalisation 
rates for cardiac conditions, by Indigenous 
status, 2010–13 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 6.1b: Trends in age-standardised 
hospitalisation rates for cardiac conditions, by 
Indigenous status 
 
Indigenous Non-Indigenous 
 
Source: AIHW NHMD. 
Figure 6.1c: Age-specific hospitalisation rates for cardiac conditions, by Indigenous status, age  
and sex, 2010–13 
 
 
Note: Data were reported by patient’s place of usual residence. 
Source: AIHW NHMD. 
Figure 6.1d: Age-standardised hospitalisation 
rates for cardiac conditions, by Indigenous 
status and state and territory, 2010–13 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 6.1e: Age-standardised hospitalisation 
rates for cardiac conditions, by Indigenous 
status and region, 2009–12 
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Measure 6.2: Cardiac mortality 
(i) Cardiac mortality—age-standardised rates of cardiac mortality, by Aboriginal and Torres 
Strait Islander status.  
(ii) Cardiac mortality—age-standardised rates of in-hospital mortality for patients admitted 
with cardiac conditions, by Aboriginal and Torres Strait Islander status. 
Why it is important 
The mortality rate for cardiac conditions provides a broad indicator of the effectiveness of 
early risk assessment and preventative care, timely diagnosis of heart disease and heart 
failure, and guideline-based treatment. 
Results 
6.2 (i) Deaths from cardiac conditions 
Nationally: In the period 2008–2012, in New South Wales, Queensland, Western Australia, 
South Australia and the Northern Territory combined, there were 2,353 Indigenous deaths 
due to cardiac conditions (a rate of 81 per 100,000 people). 
Indigenous status: The age-standardised death rate due to cardiac conditions for Indigenous 
people was 1.6 times that of non-Indigenous people (212 and 133 per 100,000, respectively) 
(Figure 6.2a). 
Time trend: The age-standardised death rate due to cardiac conditions for Indigenous 
people declined by 41% between 1998 and 2012, from 347 to 215 per 100,000 people. There 
were also declines in non-Indigenous mortality due to cardiac conditions (38%), and in the 
rate difference (46%) over this period (Figure 6.2b). 
Age and sex:  
• In all age groups, Indigenous males had a higher cardiac mortality rate than Indigenous 
females (Figure 6.2c). 
• While mortality rates for a cardiac condition were similar for Indigenous and 
non-Indigenous Australians aged 65 and over, younger Indigenous people died of 
cardiac conditions at a higher rate than non-Indigenous people. The difference was most 
pronounced for those aged 35–44 (rate ratio of 8 for males and 15 for females). 
Jurisdiction: Mortality rates for a cardiac condition were highest in the Northern Territory 
(132 per 100,000) followed by Western Australia (104 per 100,000) (Figure 6.2d). 
Things to consider 
• Mortality data are reported for five jurisdictions only (New South Wales, Queensland, 
Western Australia, South Australia and the Northern Territory). The other jurisdictions 
have a small number of Indigenous deaths, and identification of Indigenous deaths in 
their death registration systems is relatively poor, making the data less reliable (for more 
information also see Appendix B). 
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Note: Includes NSW, Qld, WA, SA and NT combined. 
Source: AIHW NMD. 
Figure 6.2a: Age-standardised cardiac mortality 
rate, by Indigenous status, 2008–2012 
 
Note: Includes NSW, Qld, WA, SA and NT combined. 
Source: AIHW NMD. 
Figure 6.2b: Trends in age-standardised cardiac 
mortality rate, by Indigenous status 
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Note: Includes NSW, Qld, WA, SA and NT combined. 
Source: AIHW NMD. 
Figure 6.2c: Age-specific cardiac mortality rate, by Indigenous status, age and sex, 2008–2012 
 
 
 
Source: AIHW NMD. 
Figure 6.2d: Cardiac mortality rate for 
Indigenous people, by state and territory,  
2008–2012 
 
 
0
50
100
150
200
250
Indigenous status
Indigenous Non-Indigenous
Deaths per 100,000
1998 2000 2002 2004 2006 2008 2010 2012
Year
0
100
200
300
400
Non-Indigenous
Indigenous
Deaths per 100,000
Males Females
    0
  200
  400
  600
  800
1,000
1,200
0–34 35–44 45–54 55–64 65+
Deaths per 100,000
Age group (years)
Males Females
    0
  200
  400
  600
  800
1,000
1,200
0–34 35–44 45–54 55–64 65+
Deaths per 100,000
Age group (years)
0
50
100
150
Jurisdiction
NSW Qld WA SA NT
Deaths per 100,000
 56 Better Cardiac Care measures for Aboriginal and Torres Strait Islander people 2015 
6.2 (ii) In-hospital deaths for patients admitted with cardiac conditions 
Nationally: Between 2008–13, there were 914 in-hospital deaths of Indigenous people who 
were admitted for cardiac conditions (a rate of 29 per 100,000 population). 
Indigenous status: The age-standardised in-hospital death rate for Indigenous people 
admitted with cardiac conditions was almost twice that of non-Indigenous people (70 and 38 
per 100,000, respectively) (Figure 6.2e). 
Time trend: There was an overall decline in both Indigenous and non-Indigenous in-hospital 
mortality for patients admitted with cardiac conditions (Figure 6.2f). 
Age and sex: 
• In all age groups, Indigenous males admitted with cardiac conditions had a higher  
in-hospital mortality rate than Indigenous females (Figure 6.2g). 
• In-hospital mortality rates for Indigenous people admitted with cardiac conditions were 
higher than those for non-Indigenous people in all age groups. The difference was most 
pronounced for those aged 35–44 for males (a rate ratio of 6) and those aged 45–54 for 
females (a rate ratio of 8). 
Things to consider 
• Data by jurisdiction could not be provided as they were not comparable due to different 
practices of recording deaths in the NHMD. Some jurisdictions recorded deaths in 
emergency departments as in-hospital deaths for admitted patients, while others did not. 
Including emergency department data would have resulted in an overestimate of the 
national rates presented in this report and would have potentially had an impact on the 
comparisons of Indigenous and non-Indigenous rates. 
• In-hospital mortality rates may also be affected by different approaches to pre- and 
post-hospital care, and should therefore be interpreted in the context of overall cardiac 
mortality. 
• While the indicator refers to rates for people, the data presented for this indicator are 
based on rates for hospitalisations. Hospitalisations ending in transfer to another acute 
hospital were excluded but this still does not address multiple hospitalisations of an 
individual in a single reporting period. As a result, the denominator includes all 
episodes of hospitalisations for cardiac conditions, including multiple episodes for the 
same person, while the numerator is a single event associated with one of the hospital 
episodes in the denominator.  
• There is some under-identification of Indigenous people in the NHMD. 
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Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 6.2e: Age-standardised in-hospital 
mortality rate for patients admitted with a 
cardiac condition, by Indigenous status,  
2008–13 
 
Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 6.2f: Trends in in-hospital 
age-standardised mortality rate for patients 
admitted with a cardiac condition, by 
Indigenous status 
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Note: Includes NSW, Vic, Qld, WA, SA and NT combined. 
Source: AIHW NHMD. 
Figure 6.2g: Age-specific in-hospital mortality rate for patients admitted with a cardiac condition, 
by Indigenous status, age group and sex, 2008–13 
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3 Data development requirements 
There are 17 Better Cardiac Care measures that require further data development work to 
enable full reporting, including 8 measures for which partial data were provided in this 
report. The data development work covers a range of activities such as modifying existing 
collections and establishing new data collections. Of the 17 measures requiring data 
development: 
• 1 has data development activity currently underway that will enable future reporting 
(measure 1.2) 
• 9 require modifications to existing data collections (measures 3.1, 3.2, 3.3, 3.4, 4.4, 5.1, 5.2, 
5.3 and 5.4)  
• 4 may be reportable through linkage of different data collections (measures 3.5, 4.1, 4.2 
and 4.3), with 4 requiring modifications to existing data plus data linkage within the 
hospital morbidity data collection (measures 3.1, 3.2, 3.3 and 3.4) and 1 requiring  
modifications to existing data plus data linkage of different collections (measure 4.4) 
• 3 require the establishment of new data collections (1.3, 2.2 and 2.3).  
The following section describes the further data development work required. Table 3.1 
summarises the data development needed to report on each of the measures (and the 
estimated time frames for this work). Table 3.2 provides details of the data development 
required for each measure. 
Data development relevant to Better Cardiac Care 
currently underway  
There are currently very limited national data on the provision of primary health-care 
services in Australia. The exception to this is the national key performance indicator (nKPI) 
data collection for Indigenous primary health-care services. Information is collected on 21 of 
the 24 nKPIs that received in-principal approval from AHMAC for reporting; these focus on 
chronic disease risk factors, prevention and management, and maternal and child health. A 
number of data items collected are highly relevant to the Better Cardiac Care project (health 
assessments, smoking status, overweight and obesity, kidney function test, diabetes 
management and blood pressure for people with diabetes). Currently, data are collected only 
from all Indigenous-specific primary health-care services that are funded by the Australian 
Government, but the collection will be progressively rolled out to include all state and 
territory funded services, starting from mid-2015.  
Measure 1.2 requires data on whether people without diagnosed cardiac disease have had a 
cardiovascular disease risk assessment and stratification in the previous 2 years. The nKPI 
Indigenous primary health-care data collection includes a newly developed indicator on the 
number and proportion of regular clients aged 35 to 74 who have had an absolute 
cardiovascular disease risk assessment as per national guidelines. Data for the indicator will 
be collected within the next 2 years and can be used to report this Better Cardiac Care 
measure.  
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Table 3.1: Better Cardiac Care measures: summary of data development requirements 
Measure 
Likely data 
source 
Time 
frame 
Data development underway 
1.2 Number/per 1,000 peoples ≥20 years of age without cardiac disease with cardiovascular risk 
assessment and stratification in the last 2 years  nKPI underway Short term 
Modify existing collections 
3.1 Proportion of people with STEMI: (a) treated by primary PCI, (b) treated with fibrinolysis NHMD Medium 
term 
3.2 Proportion of people with STEMI who are not provided any reperfusion therapy NHMD Medium 
term 
3.3 Proportion of people with ACS who received diagnostic angiography or definitive revascularisation 
procedure within the index admission/within 30 days* 
NHMD Medium 
term 
3.4 Proportion of people diagnosed with ACS discharged from hospital on appropriate secondary 
prevention medicines 
NHMD Medium 
term 
4.4 Number/proportion of patients with coronary heart disease discharged on prevention medications 
and remaining on it at 3, 6 and 12 months*  
NHMD, PBS Medium 
term 
5.1 Annual incidence of all ARF episodes Extend RHD 
registers 
Medium 
term 
5.2 Proportion of all  ARF episodes that are recurrent  Modify/extend 
RHD registers 
Medium 
term 
5.3 Median proportion of scheduled benzathine penicillin doses given to patients with confirmed ARF 
or RHD in the previous 12 months 
Modify/extend 
RHD registers Long term 
5.4 Proportion of people with moderate or severe RHD who received an echocardiogram in the 
previous 12 months 
Modify/extend 
RHD registers Long term 
Data linkage required 
3.5 In-hospital, 30-day and 12-month mortality rates for people admitted to hospital with a primary 
diagnosis of AMI* 
Data linkage—
NHMD, NMD Short term 
4.1 Number/proportion of patients reviewed by a primary health-care professional within 1 week of 
discharge from hospital 
Data linkage—
NHMD, MBS Short term 
4.2 Number/proportion of patients with cardiac disease who received follow-up Medicare items within 
3 months of hospital discharge 
Data linkage— 
NHMD, MBS Short term 
4.3 Number/proportion of patients with cardiac disease reviewed by a specialist physician within 
3/12 months of discharge  
Data linkage— 
NHMD, MBS Short term 
4.4 Number/proportion of patients with coronary heart disease discharged on prevention medications 
and remaining on it at 3, 6 and 12 months*  
Data linkage—
NHMD, PBS 
Medium 
term 
No current data sources 
1.3 Proportion of people with risk factors for cardiac disease with evidence of primary care 
practitioner follow-up 
New collection Long term 
2.2 Number/proportion of people who received diagnostic services within 30 days of referral  New collection Long term 
2.3 Proportion of people with suspected/confirmed cardiac disease reviewed by a cardiologist within 
the previous 12 months 
New collection Long term 
* Indicates measure that requires modifications to the NHMD and data linkage.  
PBS = Pharmaceutical Benefits Scheme. 
Note: Shading indicates those measures for which some data were reported. 
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Modifications required to existing collections 
National Hospital Morbidity Database  
In order to report on 3 of the measures, the NHMD needs to capture the following 
information that is currently not included: 
• Measure 3.3 requires timing information on when cardiac procedures were performed.   
• Measures 3.1 and 3.2 require the collection of information on treatment with fibrinolysis 
for people with STEMI; measure 3.1 also requires information on the timing of treatment. 
• Measures 3.4 and 4.4 require the collection of information on medications provided on 
discharge from hospital. 
The best way to capture this information, including modifications required to state-based 
collections, needs to be further investigated.  
In addition, for all indicators that use the NHMD, data linkage between records in the 
NHMD would provide better estimates of the number of people hospitalised than the 
method used in this report. 
Rheumatic Heart Disease registers 
Consistent national data on ARF are not available. The data provided in the report were 
drawn from the Queensland, Western Australian and Northern Territory registers where 
ARF is a notifiable disease. South Australia established an RHD register in 2012 but has yet 
to provide data for national reporting. But all these registers require some data development 
to fully report on measures 5.1 to 5.4. In addition, those jurisdictions that do not have a 
register (New South Wales, Victoria, Tasmania and the Australian Capital Territory) need to 
establish registers or some other mechanism for collecting the information required.  
Data linkage of existing collections 
There are 9 measures for which data are likely to be available through data linkage. The time 
frames for these data need to incorporate the relevant clearance processes required to 
undertake national data linkage.  
National Hospital Morbidity Database 
Measures 3.1, 3.2, 3.3, 3.4 and 3.5 report on people; however, individuals are not identified in 
the NHMD, nor are associated hospitalisations able to be grouped together. In this report, 
the number of people was estimated by excluding hospitalisations ending in transfer to 
another acute hospital so that only the ‘last’ hospitalisation episode is counted. But this 
method has some limitations. Ethics approval for data linkage within the NHMD based on a 
person identifier will be sought to improve the estimate of people for future reports. 
National Hospital Morbidity and National Mortality Databases 
Measure 3.5 includes 30-day and 12-month mortality following discharge from hospital. 
Data linkage between the NHMD and the NMD is required to fully report on this measure.  
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National Hospital Morbidity and Medicare Benefits Schedule 
databases 
Measures 4.1, 4.2 and 4.3 require data on care provided to cardiac patients following 
discharge from hospital. Data linkage between the NHMD and the MBS database should be 
further explored to determine if this can provide the required data. Otherwise new data 
collections may be required. 
National Hospital Morbidity and Pharmaceutical Benefits Scheme 
databases 
Measure 4.4 requires data on whether cardiac patients have remained on preventative 
medications following release from hospital. Data linkage between the NHMD and the 
Pharmaceutical Benefits Scheme database should be further explored to determine if this can 
provide the required data. Otherwise new data collections may be required. 
No current data sources 
Measures 1.3, 2.2 and 2.3 require data that are not available from current sources. These are 
measures of primary care practitioner follow-up for those at risk of cardiac conditions, 
referrals to diagnostic services, and review by cardiologists for those with cardiac conditions. 
These were initially developed as service level measures that could potentially be available 
through clinical audits. Options to collect information for these measures, including the 
development of new data collections, need to be developed further. 
Next steps 
The report provides the currently available national data on the Better Cardiac Care 
measures. It also provides an initial assessment of the data development work required and 
likely time frames for full reporting on these measures. More detailed data development 
plans and requirements for the various data collections need to be developed. 
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Table 3.2: Details of data developments required for each Better Cardiac Care measure  
Measure Possible data source and data development requirements 
1.2 Number and proportion of Aboriginal and Torres Strait Islander peoples aged 20 and 
over without known cardiac disease with a documented absolute cardiovascular risk 
assessment and stratification in the last 2 years per 1,000 Aboriginal and Torres Strait 
Islander service population 
No data were available. The nKPI data collection, which covers primary health-care organisations 
funded to provide services to Aboriginal and Torres Strait Islander people, is developing an indicator 
to collect data on the number and proportion of regular clients aged 35 to 74 who have had an 
absolute cardiovascular disease risk assessment with results at specified levels. These data will be 
collected within the next 2 years and can be used to report on this Better Cardiac Care measure.  
1.3 Proportion of those Aboriginal and Torres Strait Islander people identified as having 
elevated risk of cardiac disease in the previous 2 years, with documented evidence of 
primary care practitioner follow-up, including the proportion commenced on 
anti-hypertensive and lipid-lowering therapy and proportion of smokers offered an 
evidence-based smoking cessation intervention 
Proxy data from the AATSIHS were provided. This measure was developed as a service level 
measure. The data from the AATSIHS captures only a component of the measure. It is a complicated 
measure requiring long-term follow-up of clients. This measure requires the development of an 
appropriate data collection or clinical audits to enable reporting.  
2.2 Number and proportion of Aboriginal and Torres Strait Islander people referred for 
initial diagnostic services receiving the appropriate test within 30 days of referral, by region  
No data were available. This measure was developed as a service-level measure and requires the 
development of an appropriate data collection or clinical audits to enable reporting. 
2.3 Proportion of Aboriginal and Torres Strait Islander people with suspected or confirmed 
cardiac disease reviewed by a cardiologist within the previous 12 months, in comparison 
with other Australians 
No data were available. This measure was developed as a service-level measure and requires the 
development of an appropriate data collection or clinical audits to enable reporting. 
3.1 Proportion of people with STEMI who present within 12 hours of symptom onset and 
are eligible to receive emergency reperfusion therapy who are (a) treated by primary PCI, 
(b) treated with fibrinolysis 
NHMD data were available for part (a) hospital admissions for which PCI was reported. But data on 
treatment with fibrinolysis were not available and data modifications to the NHMD are required to 
collect this. No data were available on whether treatment is provided within 12 hours of symptom 
onset. Presentations to emergency departments are captured in the National Non-admitted Patient 
Emergency Department Care database, which may be able to capture these data. 
3.2 Proportion of people with STEMI who are not provided any reperfusion therapy, by 
Aboriginal and Torres Strait Islander status 
No data were available. The NHMD does not include information on clients treated with fibrinolysis 
(pharmacologic reperfusion). Data modifications to the NHMD are required to collect data on 
treatment with fibrinolysis.   
3.3 Proportion of people with an ACS who received diagnostic angiography or a definitive 
revascularisation procedure (PCI or coronary artery bypass graft) within the index 
admission and 30 days of the index admission, by Aboriginal and Torres Strait Islander 
status 
Data from the NHMD were available on people admitted to hospitals with ACS who received the two 
procedures. This data collection does not include information on whether treatment was provided 
within 30 days of index admission. Data modifications to the NHMD are required to fully report on this 
measure.   
3.4 Proportion of Aboriginal and Torres Strait Islander people diagnosed with ACS (STEMI 
and non-STEMI) discharged from hospital on appropriate medicines for secondary 
prevention according to guidelines, specifically aspirin or other antiplatelet agent, statin, 
ACE-inhibitor or angiotensin receptor blocker and beta-blocker 
No data were available as the NHMD does not have data on medications on discharge. Data 
modifications to the NHMD are required to collect data on medications on discharge. 
 3.5 In-hospital, 30-day and 12-month mortality rates, for people admitted to hospital with a 
primary diagnosis of AMI, by Aboriginal and Torres Strait Islander status 
The NHMD data available in this report covered only part of this measure—in-hospital mortality rates. 
Data linkage between the NHMD and the NMD is required to report on 30-day and 12-month 
mortality rates. Some jurisdictions have linked data and are able to report on the full measure. 
 (continued) 
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Table 3.2 (continued): Details of data developments required for each Better Cardiac Care measure  
Measure Possible data source and data development requirements 
4.1 Number and proportion of patients reviewed by a primary health-care professional 
within 1 week of discharge from hospital, by Aboriginal and Torres Strait Islander status 
and region 
No data were available. Data may be available through data linkage between the MBS and the 
NHMD—further investigation required.  
4.2 Number and proportion of patients with documented evidence of receiving a Medicare 
Chronic Disease Management item (such as a Team Care Arrangement, GPMP or Allied 
Health Service item) within 3 months of discharge from hospital, by Aboriginal and Torres 
Strait Islander status and region 
The MBS data reported in this report captured the Medicare Chronic Disease Management items for 
all Indigenous persons, not just those discharged from hospital. Full data may be available through 
data linkage between the MBS and the NHMD. 
4.3 Number and proportion of Aboriginal and Torres Strait Islander patients with cardiac 
disease reviewed by a specialist physician within 3 months and 12 months of discharge 
from hospital, by region 
No data were available. Data may be available through data linkage between the MBS and the 
NHMD—further investigation required. 
4.4 Number and proportion of Aboriginal and Torres Strait Islander people with a diagnosis 
of coronary heart disease prescribed secondary prevention medications (aspirin or other 
antiplatelet agent, a statin, an ACE inhibitor or angiotensin receptor blocker, and a 
beta-blocker, as appropriate) at discharge and remaining on their medications at 3, 6 and 
12 months post-discharge, by region 
No data were available as the NHMD does not have data on medications at discharge. Data 
modifications to the NHMD are required to collect data on medications on discharge. In order to get 
information on people remaining on medications, data linkage between the NHMD and the 
Pharmaceutical Benefits Scheme should be investigated.  
5.1 Annual incidence of all ARF episodes, by Aboriginal and Torres Strait Islander status Consistent national data on the incidence of ARF are not available. The data currently available are 
drawn from the RHDRs in Qld, WA and the NT. But only the NT and WA can separate recurrent and 
new cases. The data provided therefore includes initial and recurrent cases for the NT, and initial, 
recurrent and probable cases for Qld and WA. SA established an RHDR in 2012 but has yet to 
provide data for national reporting. In order to report complete national data for measures 5.1 and 
5.2, those jurisdictions with existing registers need to collect information on both initial and recurrent 
cases and those jurisdictions that do not have a register need to establish one to collect this 
information. 
5.2 Proportion of all ARF episodes that are recurrent, by Aboriginal and Torres Strait 
Islander status  
Data were provided from the RHDR for the NT only. See measure 5.1 for data development required 
in other jurisdictions. 
5.3 Median proportion of scheduled benzathine penicillin doses given to patients with 
confirmed ARF or RHD in the preceding 12 months, by Aboriginal and Torres Strait 
Islander status 
Data were provided from the RHDR for the NT only, but NT can report only on ‘Adherence to 
secondary prophylaxis in the previous 12 months’. Modifications are required to the NT register to 
fully report on this measure. Qld, WA and SA, which have a register, need to ensure this information 
is collected. The remaining jurisdictions need to set up registers or other mechanisms to collect this 
information. 
5.4 Proportion of people with moderate or severe RHD who received an echocardiogram 
in the previous 12 months, by Aboriginal and Torres Strait Islander status 
No data were provided. Qld, WA, SA and the NT have RHDRs but do not collect this information. In 
these jurisdictions, it would need to be added to the register. The remaining jurisdictions need to set 
up registers or other mechanisms to collect this information. 
Note: As well as the data developments outlined in the table, for all indicators that use the NHMD, data linkage between records in the NHMD would provide better estimates of the number of people hospitalised than the 
method used in this report.
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Appendix A: Technical specifications  
Table A1: Original measures and measures reported 
Measure agreed at Better Cardiac Care Forum  Measure reported 
1.1 Number and proportion of regular Aboriginal and 
Torres Strait Islander clients of health services who 
received an MBS Health Assessment within the previous 
12 months 
Data were reported for Aboriginal and Torres Strait Islanders aged 
25 and over with an MBS Health Assessment due to the small 
numbers of those aged under 25. 
1.3 Proportion of those Aboriginal and Torres Strait 
Islander people identified as having elevated risk of 
cardiac disease in the previous 2 years, with documented 
evidence of primary care practitioner follow-up, including 
the proportion commenced on anti-hypertensive and lipid-
lowering therapy and proportion of smokers offered an 
evidence-based smoking cessation intervention 
No data on primary care practitioner follow-up were available so 
AATSIHS data were provided as a proxy. The measure reported 
was: (a) % of Indigenous people without circulatory conditions, 
and at high risk of cardiac disease who had their blood pressure 
checked in the previous 2 years; (b) % of Indigenous people at 
high risk of cardiac disease who were current smokers, who saw a 
doctor, health professional or specialist and discussed quitting 
smoking. 
2.1 Number and proportion of regular Aboriginal and 
Torres Strait Islander clients of health services who had 
relevant Medicare-listed diagnostic items claimed in the 
previous 12 months, by region, in comparison with other 
Australians 
Same as agreed measure. 
3.1 Proportion of people with STEMI who present within 
12 hours of symptom onset and are eligible to receive 
emergency reperfusion therapy who are (a) treated by 
primary PCI, (b) treated with fibrinolysis 
Data were not available to assess whether patients with STEMI 
presented to emergency within 12 hours of symptom onset, so 
data on all people presenting with STEMI were reported. No data 
were available on whether treated with fibrinolysis so this was not 
reported. No data were available on whether patients were eligible 
for reperfusion. Data were reported for those aged 18 and over.  
3.3 Proportion of people with an ACS who received 
diagnostic angiography or a definitive revascularisation 
procedure (PCI or coronary artery bypass graft) within the 
index admission and 30 days of the index admission, by 
Aboriginal and Torres Strait Islander status  
Data were reported on estimates of people with ACS who received 
diagnostic angiography or a definitive revascularisation procedure 
within their period of care. Data were not available on whether 
these were received within 30 days of index admission. Data were 
reported for those aged 18 and over. 
3.5 In-hospital, 30-day and 12-month mortality rates for 
people admitted to hospital with a primary diagnosis of 
AMI, by Aboriginal and Torres Strait Islander status 
Data were reported on in-hospital mortality for people aged 35 and 
over admitted to hospital with a principal diagnosis of AMI. No 
national data were available on 30-day and 12-month mortality 
since hospitalisation.  
4.2 Number and proportion of patients with documented 
evidence of receiving a Medicare Chronic Disease 
Management item (such as a Team Care Arrangement, 
GPMP or Allied Health Service item) within 3 months of 
discharge from hospital, by Aboriginal and Torres Strait 
Islander status and region 
Data were reported on all people with cardiac disease receiving a 
Medicare Chronic Disease Management item. Data were not 
available for patients discharged from hospital. 
5.1 Annual incidence of all ARF episodes, by Aboriginal 
and Torres Strait Islander status 
For some registers, data on new and recurrent cases could not be 
separated, so data were reported on both new and recurrent 
cases for Qld, WA and the NT combined. Consistent national data 
were not available. 
5.2 Proportion of all acute rheumatic care episodes that 
are recurrent, by Aboriginal and Torres Strait Islander 
status  
Same as agreed measure. But data were reported on recurrent 
episodes for the NT only. Data were not available for other 
jurisdictions. 
5.3 Median proportion of scheduled benzathine penicillin 
doses given to patients with confirmed ARF or RHD in the 
preceding 12 months, by Aboriginal and Torres Strait 
Islander status 
Data were reported on % of required doses of benzathine 
penicillin received in the previous 12 months for the NT only. 
6.1 Age-standardised rates of hospitalisation for a cardiac 
condition, by Aboriginal and Torres Strait Islander status 
Same as agreed measure. 
6.2 Age-standardised rates of cardiac mortality, by 
Aboriginal and Torres Strait Islander status 
Same as agreed measure. As well, an indicator of in-hospital 
mortality for patients admitted with cardiac conditions was reported. 
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Table A2: Technical specifications for Better Cardiac Care measures with data reported 
No. Description Calculation Numerator Denominator 
Age group 
(years) Definitions Data sources 
1.1 Proportion of people aged 25 and 
over who received an MBS 
Health Assessment within the 
previous 12 months 
Numerator ÷ 
Denominator x 
100 
 
Number of people who had an 
MBS Health Assessment (Item 
715, A14, 701, 703, 705 or 
707) billed to the MBS within 
the financial year. 
Population at the middle of the 
financial year, calculated from the 
average of the populations at 
30 June at the beginning and end 
of the financial year. 
25 and over  MBS and ABS 
population data 
1.3(i) Proportion of Indigenous people 
aged 18 and over living in 
non-remote areas without a 
current and long-term circulatory 
condition who were at high risk of 
cardiac disease who had their 
blood pressure checked in the 
last 2 years 
Numerator ÷ 
Denominator x 
100 
 
Number of Indigenous people 
living in non-remote areas 
without a current and long-term 
circulatory condition who were 
at high risk of cardiac disease 
who had their blood pressure 
checked in the previous 2 
years. 
Number of Indigenous people living 
in non-remote areas without a 
current and long-term circulatory 
condition who were at high risk of 
cardiac disease. 
18 and over Without a current and long-term 
circulatory condition—people who did 
not report any current or long-term 
heart or circulatory condition, 
comprising ischaemic heart diseases; 
other heart diseases; tachycardia; 
cerebrovascular diseases; oedema; 
diseases of arteries, arterioles and 
capillaries; diseases of veins and 
lymphatic vessels etc.; other diseases 
of the circulatory system and symptoms 
or signs involving the circulatory 
system. 
At high risk of cardiac disease— 
comprises people who reported having 
one or more of the following: 
self-reported Type 2 diabetes; 
self-reported hypertensive disease or 
measured high blood pressure (systolic 
or diastolic blood pressure >140/90 
mmHg); self-reported high cholesterol 
or current smoker (includes those who 
smoked daily, at least weekly, or less 
than weekly). 
ABS 2012–13 
AATSIHS 
(continued) 
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Table A2 (continued): Technical specifications for Better Cardiac Care measures with data reported 
No. Description Calculation Numerator Denominator Age group 
(years) 
Definitions Data sources 
1.3(ii) Proportion of Indigenous people 
aged 18 and over without a 
current and long-term circulatory 
condition who were at high risk of 
cardiac disease, who saw a 
doctor/health professional or 
specialist in the last 12 months 
and were current smokers who 
discussed quitting smoking 
Numerator ÷ 
Denominator x 
100 
Number of Indigenous people 
without a current and long-term 
circulatory condition who were 
at high risk of cardiac disease, 
who saw a doctor/health 
professional or specialist in the 
previous12 months and were 
current smokers who discussed 
quitting smoking. 
Number of Indigenous people 
without a current and long-term 
circulatory condition, who were at 
high risk of cardiac disease, who 
saw a doctor/health professional or 
specialist in the previous 12 months 
and who were current smokers. 
18 and over Without a current and long-term 
circulatory condition—1.3(i) above. 
At high risk of cardiac disease—1.3(i) 
above. 
Current smokers— includes those who 
smoked daily, at least weekly, or less 
than weekly. 
ABS 2012–13 
AATSIHS 
2.1 Proportion of people who had 
relevant Medicare-listed 
cardiac-related diagnostic items 
claimed in the previous 
12 months 
Numerator ÷ 
Denominator x 
100 
Number of people who had 
relevant Medicare-listed 
cardiac-related diagnostic items 
(listed in Table A3) claimed in 
the financial year. 
Population at the middle of the 
financial year, calculated from the 
average of the populations at 
30 June at the beginning and end 
of the financial year. 
All ages  MBS and ABS 
population data 
3.1 Proportion of people aged 18 and 
over with a STEMI who are 
treated by PCI, by Aboriginal and 
Torres Strait Islander status 
Numerator ÷ 
Denominator x 
100 
Number of hospitalisations with 
a principal diagnosis of STEMI 
(ICD-10-AM codes I21.0, I21.1, 
I21.2 and I21.3), and a care 
type of ‘acute care’, and 
urgency of admission of 
‘emergency’, and separation 
mode not ‘transferred to 
another acute hospital’, with a 
procedure code related to PCI 
(listed in Table A4). 
Number of hospitalisations with a 
principal diagnosis of STEMI 
(ICD 10-AM codes I21.0, I21.1, 
I21.2 and I21.3), and a care type of 
‘acute care’, and urgency of 
admission of ‘emergency’, and 
separation mode not equal to 
‘transferred to another acute 
hospital’. 
18 and over  NHMD 
(continued) 
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Table A2 (continued): Technical specifications for Better Cardiac Care measures with data reported 
No. Description Calculation Numerator Denominator Age group 
(years) 
Definitions Data sources 
3.3 Proportion of people with ACS 
who received diagnostic 
angiography or a definitive 
revascularisation procedure (PCI 
or CABG) within the period of 
care 
Numerator ÷ 
Denominator x 
100 
Number of hospitalisations with 
a principal diagnosis of STEMI 
(ICD-10-AM codes I21.0, I21.1, 
I21.2 and I21.3), NSTEACSI 
(I21.4), unspecified AMI (I21.9) 
or unstable angina (I20.0), and 
a care type of ‘acute care’, and 
urgency of admission of 
‘emergency’, and separation 
mode not equal to ‘transferred 
to another acute hospital’, with 
a procedure code related to 
diagnostic angiography or PCI 
or CABG (listed in Table A4). 
Number of hospitalisations with a 
principal diagnosis of STEMI 
(ICD-10-AM codes I21.0, I21.1, 
I21.2 and I21.3), NSTEMI (I21.4), 
unspecified AMI (I21.9) or unstable 
angina (I20.0), and a care type of 
‘acute care’, and urgency of 
admission of ‘emergency’, and 
separation mode not equal to 
‘transferred to another acute 
hospital’. 
18 and over Period of care—contiguous episodes 
of care, separated only by a transfer 
within or between hospitals, are 
combined into a single ‘period of 
care’. This was estimated by 
excluding hospitalisations ending in 
transfer to another acute hospital, so 
that only the ‘last’ hospitalisation was 
counted. 
NHMD 
3.5 Proportion of people aged 35 and 
over, admitted to hospital with a 
principal diagnosis of AMI who 
died in hospital, by Aboriginal and 
Torres Strait Islander status 
Numerator ÷ 
Denominator x 
100 
Number of hospitalisations with 
a principal diagnosis of AMI 
(ICD-10-AM code I21), and a 
care type of ‘acute care’, and 
urgency of admission of 
‘emergency’, and separation 
mode of ‘died’. 
Number of hospitalisations with a 
principal diagnosis of AMI 
(ICD-10-AM code I21), and a care 
type of ‘acute care’, and urgency of 
admission of ‘emergency’, and 
separation mode not equal to 
‘transferred to another acute 
hospital’. 
35 and over  NHMD 
4.2 Proportion of people with cardiac 
disease who received a Medicare 
Chronic Disease Management 
item 
(i)  Team Care Arrangement 
(ii)  GPMP 
(iii) Allied Health Service(s) 
Numerator ÷ 
Denominator x 
100 
Number of people with cardiac 
disease who received a 
Medicare Chronic Disease 
Management item 
(i)  Team Care Arrangement 
(ii)  GPMP 
(iii) Allied Health Service(s). 
Number of people with cardiac 
disease. 
All ages People with cardiac disease—those 
who had relevant Medicare-listed 
cardiac items (listed in Table A4) 
claimed in the financial year. 
MBS 
5.1 Incidence (new and recurrent 
cases) of ARF, by Aboriginal and 
Torres Strait Islander status 
Numerator ÷ 
Denominator x 
100,000 
Number of new and recurrent 
cases of ARF in the calendar 
year. 
Population at 30 June. All ages  Qld, WA and NT 
RHDR data, ABS 
population data 
(continued)  
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Table A2 (continued): Technical specifications for Better Cardiac Care measures with data reported 
No. Description Calculation Numerator Denominator Age group Definitions Data sources 
5.2 Proportion of all ARF episodes 
that are recurrent, by Aboriginal 
and Torres Strait Islander status 
Numerator ÷ 
Denominator x 
100 
Number of recurrent cases of 
ARF in the calendar year. 
Number of new and recurrent cases 
of ARF in the calendar year. 
All ages  NT RHDR 
5.3 Percentage of required doses of 
benzathine penicillin received in 
previous 12 months for 
Indigenous persons on the 
ARF/RHD program 
Numerator ÷ 
Denominator x 
100 
Number of people on the 
AFR/RHD program who 
received: 
• less than 50%  
• 50% to 80% 
• greater than 80% 
of required doses in the 
previous 12 months. 
Number of people on the AFR/RHD 
program. 
All ages  NT RHDR 
6.1 Cardiac morbidity—
age-standardised rates of 
hospitalisation for a cardiac 
condition, by Aboriginal and 
Torres Strait Islander status 
Crude rate: 
Numerator ÷ 
Denominator x 
1,000 
Age-
standardised 
rate (ASR): 
𝐴𝑆𝑅 = ∑ 𝑁𝑖𝑖 𝑝𝑖 ∑ 𝑁𝑖𝑖⁄  
where: 
pi is the 
age-specific 
rate for age 
group i in the 
population 
being studied  
Ni is the 
population of 
age group i in 
the standard 
population. 
Number of hospitalisations with 
a principal diagnosis of cardiac 
condition (ICD-10-AM codes 
I00–I52, which includes ARF, 
chronic RHDs, hypertensive 
diseases, ischaemic heart 
diseases, pulmonary heart 
disease and diseases of 
pulmonary circulation and other 
forms of heart disease) and a 
care type not equal to ‘new 
born—unqualified days only’ or 
‘organ procurement—
posthumous’ or ‘hospital 
boarder’. 
Population at the middle of the 
financial year, calculated from the 
average of the populations at 
30 June at the beginning and end 
of the financial year. 
All ages  NHMD and 
ABS 
population data 
(continued) 
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Table A2 (continued): Technical specifications for Better Cardiac Care measures with data reported 
No. Description Calculation Numerator Denominator Age group Definitions Data sources 
6.2(i) Cardiac mortality—
age-standardised rates of 
cardiac mortality, by 
Aboriginal and Torres Strait 
Islander status 
Crude rate: 
Numerator ÷ 
Denominator x 
100,000 
 𝐴𝑆𝑅 =  ∑ 𝑁𝑖𝑖 𝑝𝑖 ∑ 𝑁𝑖𝑖⁄  
where: 
pi  is the age-specific 
rate for age group i in 
the population being 
studied  
Ni is the population of 
age group i in the 
standard population. 
Number of deaths where a cardiac 
condition (ICD-10 codes I00–I52, which 
includes ARF, chronic RHDs, 
hypertensive diseases, ischaemic heart 
diseases, pulmonary heart disease and 
diseases of pulmonary circulation and 
other forms of heart disease) is the 
underlying cause of death in the 
calendar year (based on year of 
registration of death).  
Numerator data are reported for NSW, 
Qld, WA, SA and the NT (for more 
information see Appendix B). 
Population at 30 June. 
Denominator data are reported for 
NSW, Qld, WA, SA and NT (for 
more information see Appendix B). 
All ages  NMD and ABS 
population data 
6.2(ii) Cardiac mortality—
age-standardised rates of 
in-hospital mortality for 
patients admitted with 
cardiac conditions, by 
Aboriginal and Torres Strait 
Islander status 
Crude rate: 
Numerator ÷ 
Denominator x 
100,000 
 𝐴𝑆𝑅 =  ∑ 𝑁𝑖𝑖 𝑝𝑖 ∑ 𝑁𝑖𝑖⁄  
where: 
pi is the age-specific 
rate for age group i in 
the population being 
studied  
Ni is the population of 
age group i in the 
standard population. 
Number of hospitalisations with a 
principal diagnosis of cardiac condition 
(ICD-10-AM codes I00–I52, which 
includes ARF, chronic RHDs, 
hypertensive diseases, ischaemic heart 
diseases, pulmonary heart disease and 
diseases of pulmonary circulation and 
other forms of heart disease), and a 
care type not equal to ‘new born—
unqualified days only’ or ‘organ 
procurement—posthumous’ or ‘hospital 
boarder’ and a separation mode equal 
to ‘died’. 
Population at the middle of the 
financial year, calculated from the 
average of the populations at 
30 June at the beginning and end 
of the financial year. 
All ages  NHMD and 
ABS 
population data 
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Table A3: Medicare-listed cardiac-related diagnostic items 
Procedure type Medicare item Description 
ECG monitoring 11712  Multi-channel ECG monitoring and 
recording during exercise 
Echocardiography 55113, 55114, 55116 to 55119, 55120, 
55122, 55123, and 55125 
Echocardiography (includes exercise 
and pharmacological stress 
echocardiography)  
Exclude 55115 and 55121 (investigation 
of congenital heart disease) 
Cardiac catheterisation +/– PCI 38215 to 38246 Selective coronary angiography 
 38300 to 38318 Endovascular Interventional Procedures 
(PCI) 
 38200, 38203 and 38206 Cardiac catheterisation 
Table A4: Medicare-listed cardiac-related items 
Medicare item Description 
11712  Multi-channel ECG monitoring and recording during exercise 
38215 to 38246 Selective coronary angiography 
38300 to 38318 Endovascular Interventional Procedures (PCI) 
55113, 55114, 55116 to 55119, 
55120, 55122, 55123, and 55125 
Echocardiography (includes exercise and pharmacological stress echocardiography)  
Exclude 55115 and 55121 (investigation of congenital heart disease) 
38200, 38203 and 38206 Cardiac catheterisation 
38497 to 38504 Coronary artery bypass 
11708, 11709, 11710, 11711, 
11722 and 38285 
Ambulatory electrocardiography items critical in the diagnosis of cardiac arrhythmias 
Table A5: Procedure codes from the Australian Classification of Health Interventions, 7th Edition, 
2010 
Procedure ACHI code Description 
PCI 38300-00 Percutaneous transluminal balloon angioplasty of 1 coronary artery 
 38303-00 Percutaneous transluminal balloon angioplasty of ≥ 2 coronary arteries 
 38306-00 Percutaneous insertion of 1 transluminal stent into single coronary artery 
 38306-01 Percutaneous insertion of ≥ 2 transluminal stents into single coronary artery 
 38306-02 Percutaneous insertion of ≥ 2 transluminal stents into multiple coronary arteries 
 38309-00  Percutaneous transluminal coronary rotational atherectomy, 1 artery 
 38312-00 Percutaneous transluminal coronary rotational atherectomy, 1 artery with insertion of 1 stent 
 38312-01 Percutaneous transluminal coronary rotational atherectomy, 1 artery with insertion of ≥2 stents 
 38315-00 Percutaneous transluminal coronary rotational atherectomy, multiple arteries 
 38318-00 Percutaneous transluminal coronary rotational atherectomy, multiple arteries with insertion of 1 
stent 
 38318-01 Percutaneous transluminal coronary rotational atherectomy, multiple arteries with insertion of ≥ 
2 stents 
(continued)  
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Table A5 (continued): Procedure codes from the Australian Classification of Health Interventions, 
7th Edition, 2010 
Procedure ACHI code Description 
Diagnostic 
angiography 
38215-00 Coronary angiography 
 38218-00 Coronary angiography with left heart catheterisation 
 38218-01 Coronary angiography with right heart catheterisation 
 38218-02 Coronary angiography with left and right heart catheterisation 
CABG 38300-01 Open transluminal balloon angioplasty of 1 coronary artery 
 38303-01 Open transluminal balloon angioplasty of ≥ 2 coronary arteries 
 38306-03 Open insertion of 1 transluminal stent into single coronary artery 
 38306-04 Open insertion of ≥ 2 transluminal stents into single coronary artery 
 38306-05 Open insertion of ≥ 2 transluminal stents into multiple coronary arteries 
 38497-00 Coronary artery bypass, using 1 saphenous vein graft 
 38497-01 Coronary artery bypass, using 2 saphenous vein grafts 
 38497-02 Coronary artery bypass, using 3 saphenous vein grafts 
 38497-03 Coronary artery bypass, using ≥ 4 saphenous vein grafts 
 38497-04 Coronary artery bypass, using 1 other venous graft 
 38497-05 Coronary artery bypass, using 2 other venous grafts 
 38497-06 Coronary artery bypass, using 3 other venous grafts 
 38497-07 Coronary artery bypass, using ≥ 4 other venous grafts 
 38500-00 Coronary artery bypass, using 1 left internal mammary artery graft 
 38500-01 Coronary artery bypass, using 1 right internal mammary artery graft 
 38500-02 Coronary artery bypass, using 1 radial artery graft 
 38500-03 Coronary artery bypass, using 1 epigastric artery graft 
 38500-04 Coronary artery bypass, using 1 other arterial graft 
 38500-05 Coronary artery bypass, using 1 composite graft 
 38503-00 Coronary artery bypass, using ≥ 2 left internal mammary artery grafts 
 38503-01 Coronary artery bypass, using ≥ 2 right internal mammary artery grafts 
 38503-02 Coronary artery bypass, using ≥ 2 radial artery grafts 
 38503-03 Coronary artery bypass, using ≥ 2 epigastric artery grafts 
 38503-04 Coronary artery bypass, using ≥ 2 other arterial grafts 
 38503-05 Coronary artery bypass, using 1 composite graft 
 38505-00 Open coronary endarterectomy 
 90201-00 Coronary artery bypass, using 1 other graft, not elsewhere classified 
 90201-01 Coronary artery bypass, using 2 other grafts, not elsewhere classified 
 90201-02 Coronary artery bypass, using 3 other grafts, not elsewhere classified 
 90201-03 Coronary artery bypass, using ≥ 4 other grafts, not elsewhere classified 
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Appendix B: Data sources 
AIHW National Hospital Morbidity Database 
Data about admitted patient care were extracted from the AIHW NHMD, which is a 
compilation of episode-level records from admitted patient morbidity data collection 
systems in Australian hospitals in each state and territory. Information on the characteristics, 
diagnoses and care of admitted patients in public and private hospitals is provided annually 
to the AIHW by state and territory health departments.  
Analysis in this report is based on the patient’s place of usual residence. Data are based on 
financial years. 
For each hospitalisation, the principal diagnosis is reported, while additional diagnoses are 
reported if the condition affected patient management. In this report, information on 
principal diagnoses was used to identify hospitalisations for specific conditions; additional 
diagnoses have not been considered. 
Changes in the level of accuracy of Indigenous identification in hospital records will result in 
changes in the level of reported hospitalisations for Indigenous Australians. Caution should 
be used when interpreting changes over time, as it is not possible to ascertain whether a 
change in reported hospitalisations is due to changes in the accuracy of Indigenous 
identification and/or real changes in the rates at which Indigenous people were hospitalised. 
An increase in hospitalisation rates for a particular population may also reflect increased use 
of admitted patient hospital services—as opposed to other forms of health care—rather than 
a worsening of health; likewise, a decrease in hospitalisation rates may not necessarily 
indicate an improvement in health. 
Hospitalisations data presented in this report have not been adjusted for under-identification 
and are therefore likely to underestimate the true level of Indigenous hospitalisations. Also, 
hospitalisations where Indigenous status was not stated are excluded from analyses that 
compare Indigenous and non-Indigenous rates. 
The analysis of hospitalisations data by region in measures 3.1, 3.3, 3.5 and 5.1 uses the 
Australian Standard Geographical Classification Remoteness Structure, and data for the 
years 2009–12 (instead of 2010–13 used for the other analyses) as remoteness classifications 
changed in 2012–13. 
The complete NHMD data quality statement is available online at 
<http://meteor.aihw.gov.au/content/index.phtml/itemId/568730>.  
AIHW National Mortality Database 
Mortality data presented in this report were extracted from the AIHW’s NMD. These data 
are: 
• provided to the AIHW by the Registrars of Births, Deaths and Marriages in each state 
and territory, as well as by the National Coronial Information System 
• assigned codes for cause(s) of death by the Australian Bureau of Statistics (ABS).  
Due to the small number of Indigenous deaths from cardiac conditions each year, mortality 
data for the most ‘recent’ period are presented for the 5-year period 2008–2012 to allow for 
the reporting of data by age and sex.  
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Deaths registered in: 
• 2010 and earlier are based on the final version of cause of death data 
• 2011 and 2012 are based on revised and preliminary versions, respectively, and are 
subject to further revision by the ABS.  
Data for 2010 have been adjusted for the additional deaths arising from outstanding 
registrations of deaths in Queensland in 2010—see Technical note 3 in ABS 2014a for further 
details.  
Data are reported for five jurisdictions—New South Wales, Queensland, Western Australia, 
South Australia and the Northern Territory. Other jurisdictions have a small number of 
Indigenous deaths, and identification of Indigenous deaths in their death registration system 
is poor, making the data less reliable. 
The Indigenous status of a deceased person is identified through the death registration 
process. While it considered likely that most deaths of Indigenous Australians are registered, 
a proportion of these deaths are not reported as a death of an Indigenous person by the 
family, health worker or funeral director during the death registration process, leading to 
some degree of under-identification of Indigenous people in mortality data. Mortality data 
presented in this report have not been adjusted for under-identification and are therefore 
likely to underestimate the true level of Indigenous mortality (ABS 2014a). 
In this report, registered deaths where Indigenous status was not stated are excluded from 
analyses that compare Indigenous and non-Indigenous mortality rates. This applies to 5,517 
registered deaths in 2008–2012.  
Although the NMD includes information about both the underlying and associated causes of 
death, only the underlying cause is used in the analyses presented in this report.  
The data quality statements underpinning the NMD can be found in quality declaration 
summaries in the following ABS publications: 
<http://www.abs.gov.au/AUSSTATS/abs@.nsf/mf/3303.0/> 
<http://www.abs.gov.au/ausstats/abs@.nsf/mf/3302.0>. 
ABS population data 
The rates in this report were calculated using ABS estimates and projections of the 
population based on the 2011 Census (ABS 2013b, 2014b).  
For analysis by region in measure 6.1, population data using the Australian Standard 
Geographical Classification Remoteness Structure were used. These data are based on the 
2006 Census and therefore rates differ from those for the other analysis of this measure. 
ABS 2012–13 Australian Aboriginal and Torres Strait 
Islander Health Survey 
The ABS 2012–13 AATSIHS was designed to obtain national benchmark information on a 
range of health-related issues and to enable monitoring over time of the health of Indigenous 
people (ABS 2013a).  
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Overall, the AATSIHS included a nationally representative sample of around 13,000 
Indigenous people living in 8,300 private dwellings in remote and non-remote areas of 
Australia, including discrete Indigenous communities. 
MBS database 
The MBS is part of the Medicare Benefits Scheme, the aim of which is to provide an 
entitlement to benefits for medical and hospital services for all Australian residents. These 
benefits are based on fees determined for each service provided. These services are itemised, 
forming the schedule of fees. Statistics on each item are collected when benefits are paid. 
Medicare enrolment application forms are lodged by persons wishing to enrol with Medicare 
at Medicare offices in each state/territory or by mail. Information from these forms is 
entered directly into the Medicare database, which is held by the Department of Health. 
Rheumatic Heart Disease registers 
Jurisdictional data are available from Queensland, Western Australian and Northern 
Territory RHDRs. ARF has been a notifiable disease in the Northern Territory since 1994 
(RHD Australia 2012), and it became a notifiable disease in Queensland in 1999 (Queensland 
Health: Sweeny & Beard 2009) and in Western Australia in September 2007 (Western 
Australia Department of Health 2015). South Australia has had a register in place since 2012, 
but was unable to provide data for this report. 
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Appendix C: Things to consider when 
interpreting the data 
Medicare data 
Measures based on Medicare data 
The Medicare data reported come from the MBS database. It should be noted that while the 
data have been used as measures of specific activities, changes in the use of an item can 
reflect changes in billing/claiming practices or the introduction of new items and not 
necessarily changes in health care provided. 
Indigenous identification in Medicare data 
The data for measure 1.1 includes MBS item 715, which is an Indigenous-specific health 
assessment, as well as other MBS health assessments (MBS items A14, 701, 703, 705 and 707). 
The identification of Indigenous Australians in the Medicare database is not complete as it is 
based on the Voluntary Indigenous Identifier (VII). In November 2002, the ABS standard 
question on Indigenous identification was included on the Medicare enrolment application 
form. The question is asked in relation to the cardholder and any other family member 
named on the card. Responding to the question is voluntary.  
Medicare data presented in this report have been adjusted for under-identification. There are 
a number of caveats to the VII adjustment methodology, including that, as the VII sample is 
generated voluntarily, it is not truly random and cannot be fully representative of the 
Indigenous population until full coverage is achieved. There could, therefore, be biases in the 
data that are not addressed by the adjustment methodology. 
Health assessments for non-Indigenous Australians 
The MBS item 715, Health Assessments, is specifically for Indigenous Australians and is 
claimable annually. Non-Indigenous Australians are also eligible to receive health 
assessments under MBS items A14, 701, 703, 705 and 707; however, these checks are available 
only to specific groups of people and are sometimes available less frequently than the 
Indigenous specific health checks (Table C1). Therefore, the data for Indigenous and 
non-Indigenous people are not directly comparable. 
Estimate of people with a cardiac condition from MBS data 
The MBS data do not have information about whether people have a cardiac condition, so 
this was estimated based on people who had one or more of the cardiac-related MBS items in 
the previous financial year (Table A4). As some of these MBS items are diagnostic, not all 
people with these items would have cardiac conditions (as some of the tests would have 
been negative). 
Proxy measures for primary care practitioner follow-up 
The first measure for 1.3 is on whether blood pressure was checked, as a proxy for evidence 
of primary care practitioner follow-up and whether antihypertensive therapy was started. 
Data for this proxy measure is available only for non-remote areas. 
The second proxy measure for 1.3 is on whether smokers discussed quitting smoking as a 
proxy for whether smokers were offered evidence-based smoking cessation intervention. 
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Table C1: Target group and frequency of service for MBS items A14, 701, 703, 705 and 707 
Target group Frequency of service 
A Healthy Kids Check for children aged at least 3 and less than 5, who have 
received or who are receiving their 4-year-old immunisation 
Once only to an eligible patient 
A type 2 diabetes risk evaluation for people aged 40–49 (inclusive) with a high risk 
of developing type 2 diabetes as determined by the Australian Type 2 Diabetes Risk 
Assessment Tool 
Once every 3 years to an eligible patient 
A health assessment for people aged 45–49 (inclusive) who are at risk of developing 
chronic disease 
Once only to an eligible patient 
A health assessment for people aged 75 and older Provided annually to an eligible patient 
A comprehensive medical assessment for permanent residents of residential aged 
care facilities 
Provided annually to an eligible patient 
A health assessment for people with an intellectual disability Provided annually to an eligible patient 
A health assessment for refugees and other humanitarian entrants Once only to an eligible patient 
A health assessment for former serving members of the Australian Defence Force Once only to an eligible patient 
National hospital morbidity data 
Estimation of people in the National Hospital Morbidity Database  
Because individuals are not identified in the NHMD, nor are associated hospitalisations able 
to be grouped together, hospitalisations that are coded with a ‘separation mode’ of 
‘transferred to another acute hospital’ were excluded from this analysis. In this way (in 
theory) only the ‘last’ hospitalisation episode is counted, and the initial episodes are 
excluded. This method is used to avoid double counting of individual patients. It was 
validated in calculating the incidence of acute coronary events when the AIHW compared 
results from the NHMD and the NMD with results from linked hospitalisation and deaths 
data from New South Wales and Western Australia (AIHW 2014). The AIHW analysis 
indicated that the method is valid; however, there were some limitations: 
• 5%–11% of hospitalisations ending in transfer did not have a subsequent hospitalisation. 
Some of these patients could have been transferred to non-acute care facilities interstate. 
• Following transfer, 4%–7% of hospitalisations did not have a principal diagnosis of AMI 
or unstable angina. It is possible that the transfer was initiated for what was thought to 
be ACS, but subsequently was not confirmed.  
Note that for the measure presented here, patients will not be counted if they transfer to 
another hospital for recovery after a procedure. Also, this method will remove double 
counting of patients within a contiguous hospitalisation, but it will not remove double 
counting of non-contiguous hospitalisations (for example, if a patient is admitted for a heart 
attack, recovers and then 3 months later is admitted for a second heart attack, this would be 
counted as 2 people in the method used in this report). This is not a limitation of the analysis, 
as ideally the indicator would collect information on the treatment received for each event of 
a heart attack. 
Indigenous identification in the National Hospital Morbidity Database 
While there is some under-identification of Indigenous Australians in the NHMD, data for 
all states and territories are considered to have adequate Indigenous identification from 
2010–11 onwards (AIHW 2013b). For some measures, because of small numbers, the data for 
the Australian Capital Territory were combined with those for New South Wales, and the 
data for Tasmania were combined with those for Victoria. 
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Time series comparisons are based on data for the six jurisdictions that were assessed by the 
AIHW as having adequate identification of Indigenous hospitalisations from 2004–05 
onwards—namely, New South Wales, Victoria, Queensland, Western Australia, South 
Australia and public hospitals in the Northern Territory (AIHW 2010). This represents 95% 
of the Australian Indigenous population. 
PCIs are also performed in a non-admitted patient setting 
A certain proportion of PCIs are performed in a non-admitted patient setting and the 
condition or characteristics of these patients may differ considerably from that of admitted 
patients. 
Eligibility for reperfusion therapy 
Not all patients with STEMI are eligible for reperfusion because of multiple comorbidities, 
including chronic kidney disease, which increase the risks associated with PCI. However, 
eligibility for reperfusion therapy cannot be determined from administrative data sources.  
Rhematic heart disease registers 
Availability of ARF data  
The data currently available are drawn from Queensland, Western Australia and the 
Northern Territory where ARF is a notifiable disease and where register and control 
programs have been established. The incidence of ARF includes initial and recurrent cases 
for the Northern Territory and initial, recurrent and probable cases for Queensland and 
Western Australia. 
Age standardisation of ARF data 
All rates of ARF are crude rates as data required for age standardisation were not available 
from all registers. 
Diagnosis of ARF 
Currently, there is no diagnostic laboratory test for ARF, so diagnosis remains a clinical 
decision based on the identification of major and minor manifestations of the illness. 
However, the clinical appearances are non-specific and can be atypical in Aboriginal and 
Torres Strait Islander people. Accurate diagnosis hinges on early echocardiographic imaging 
to exclude or confirm rheumatic carditis; however, without an appropriate level of clinical 
suspicion to refer for echocardiogram, many cases of ARF can go undetected in the acute 
stage. 
National mortality data 
Indigenous identification in National Mortality Database 
Mortality data are reported for five jurisdictions combined—New South Wales, Queensland, 
Western Australia, South Australia and the Northern Territory. Other jurisdictions have a 
small number of Indigenous deaths, and identification of Indigenous deaths in their death 
registration systems is relatively poor, making the data less reliable. The AIHW considers the 
quality of Indigenous identification in mortality data for the five jurisdictions to be adequate 
from 1998; thus, trend data are shown in this report from that year onwards. 
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Appendix D: List of persons consulted 
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Karen Foster Department of Health and Human Services, Tasmania 
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Glossary 
acute coronary syndrome (ACS): a term used for any condition brought on by sudden, 
reduced blood flow to the heart. It includes a heart attack and unstable angina (pressure in 
the chest while at rest or doing light physical activity). 
acute myocardial infarction (AMI): a heart attack. 
acute rheumatic fever (ARF): a delayed autoimmune complication of throat infections 
caused by Group A Streptococcus. ARF can also develop following streptococcal skin 
infections, often secondary to scabies. 
admitted patient: a patient who undergoes a hospital’s admission process to receive 
treatment and/or care. This treatment and/or care is provided over a period of time and can 
occur in hospital and/or in the person’s home (for hospital-in-the-home patients). METeOR 
identifier: 268957. 
age standardisation: a set of techniques used to remove, as far as possible, the effects of 
differences in age when comparing two or more populations. 
at high risk of cardiac disease: a classification of Indigenous people based on their having 
one or more of the following: self-reported type 2 diabetes, self-reported hypertensive 
disease or measured high blood pressure (systolic or diastolic blood pressure 
 >140/90 mmHg), self-reported high cholesterol, or current smoker (includes those who 
smoked daily, at least weekly, or less than weekly). 
care type: the overall type of clinical service provided to an admitted patient during an 
episode of care (admitted care), or the type of service provided by the hospital for boarders 
or posthumous organ procurement (care other than admitted care). METeOR identifier: 
491557. Admitted patient care consists of the following categories: 
• acute care 
• rehabilitation care 
• palliative care 
• geriatric evaluation and management 
• psychogeriatric care 
• maintenance care 
• newborn care 
• other admitted patient care—this is where the principal clinical intent does not meet the 
criteria for any of the above. 
Care other than admitted care include: 
• posthumous organ procurement 
• hospital boarder.  
coronary artery bypass graft (CABG): a type of surgery that improves blood flow to the 
heart. 
current smoker: includes those who smoked daily, at least weekly, or less than weekly. 
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definitive revascularisation procedure: a procedure used to increase coronary artery blood 
flow. 
diagnostic angiography: a medical imaging technique used to visualise the inside of blood 
vessels. It allows the diagnosis of various disorders and injuries to the blood vessels. 
hospitalisation (separation): an episode of care for an admitted patient, which can be a total 
hospital stay (from admission to discharge, transfer or death) or a portion of a hospital stay 
beginning or ending in a change of care type (for example, from acute care to rehabilitation). 
index admission: the admission with a principal diagnosis of a specified condition.  
mode of separation: status at separation of a person (discharge/transfer/death) and place to 
which a person is released (where applicable). METeOR identifier: 270094. 
non-ST elevation acute coronary syndromes (NSTEACS): unstable angina (pressure in the 
chest while at rest or doing light physical activity) and non–ST elevation myocardial 
infarction (the less severe type of heart attack). 
percutaneous coronary intervention (PCI): a procedure such as stent that opens blocked or 
narrowed coronary arteries. 
period of care: a single combination of contiguous episodes of care separated only by a 
transfer within or between hospitals. This was estimated by excluding hospitalisations 
ending in transfer to another acute hospital, so that only the ‘last’ hospitalisation was 
counted. 
principal diagnosis: the diagnosis established after study to be chiefly responsible for 
occasioning an episode of admitted patient care, an episode of residential care or an 
attendance at the health care establishment. 
procedure: a clinical intervention that is surgical in nature, carries a procedural risk, carries 
an anaesthetic risk, requires specialised training and/or requires special facilities or 
equipment available only in an acute care setting. METeOR identifier: 514040. 
rheumatic heart disease (RHD): a disease that results from ongoing damage to the heart 
caused by acute rheumatic fever; it often requires cardiac surgery to repair or replace 
damaged valves. 
separation: see hospitalisation. 
ST-elevation myocardial infarction (STEMI): a type of heart attack. Heart attacks are 
divided into two types, according to their severity; a STEMI is the more severe type. 
without a current and long-term circulatory condition: a classification that excludes persons 
who reported a current and long-term heart or circulatory condition, comprising ischaemic 
heart diseases; other heart diseases; tachycardia; cerebrovascular diseases; oedema; diseases 
of arteries, arterioles and capillaries; diseases of veins, lymphatic vessels etc.; other diseases 
of the circulatory system, and symptoms or signs involving the circulatory system.   
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This is the first national report on the 21 Better Cardiac 
Care measures for Aboriginal and Torres Strait Islander 
people. It shows that:
• the age-standardised death rate due to cardiac 
conditions for Indigenous people was 1.6 times 
that for non-Indigenous people
• mortality from cardiac conditions for Indigenous 
Australians decreased by 41% between 1998 and 
2012, while access to cardiac care has improved 
over time.
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